WO2015042683A1 - Biopolymer compositions comprising a plurality of treated single-celled microorganisms - Google Patents
Biopolymer compositions comprising a plurality of treated single-celled microorganisms Download PDFInfo
- Publication number
- WO2015042683A1 WO2015042683A1 PCT/CA2013/000823 CA2013000823W WO2015042683A1 WO 2015042683 A1 WO2015042683 A1 WO 2015042683A1 CA 2013000823 W CA2013000823 W CA 2013000823W WO 2015042683 A1 WO2015042683 A1 WO 2015042683A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- celled
- microorganisms
- microorganism
- biopolymer
- gelatin
- Prior art date
Links
- 244000005700 microbiome Species 0.000 title claims abstract description 99
- 229920001222 biopolymer Polymers 0.000 title claims abstract description 95
- 239000000203 mixture Substances 0.000 title claims abstract description 33
- 238000002360 preparation method Methods 0.000 claims abstract description 12
- 108010010803 Gelatin Proteins 0.000 claims description 81
- 229920000159 gelatin Polymers 0.000 claims description 81
- 239000008273 gelatin Substances 0.000 claims description 81
- 235000019322 gelatine Nutrition 0.000 claims description 81
- 235000011852 gelatine desserts Nutrition 0.000 claims description 81
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical group [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 45
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 41
- 240000002900 Arthrospira platensis Species 0.000 claims description 40
- 235000016425 Arthrospira platensis Nutrition 0.000 claims description 40
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 claims description 40
- 239000002245 particle Substances 0.000 claims description 40
- 229940082787 spirulina Drugs 0.000 claims description 40
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 38
- 241000195649 Chlorella <Chlorellales> Species 0.000 claims description 37
- 150000003839 salts Chemical class 0.000 claims description 28
- 239000000126 substance Substances 0.000 claims description 27
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical group [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 26
- 238000000034 method Methods 0.000 claims description 26
- 230000008569 process Effects 0.000 claims description 23
- 235000019441 ethanol Nutrition 0.000 claims description 22
- 241000894006 Bacteria Species 0.000 claims description 13
- 235000003599 food sweetener Nutrition 0.000 claims description 13
- 239000011780 sodium chloride Substances 0.000 claims description 13
- 239000003765 sweetening agent Substances 0.000 claims description 13
- 102000004190 Enzymes Human genes 0.000 claims description 12
- 108090000790 Enzymes Proteins 0.000 claims description 12
- 229920002472 Starch Polymers 0.000 claims description 12
- 239000008107 starch Substances 0.000 claims description 12
- 235000019698 starch Nutrition 0.000 claims description 12
- 229920001282 polysaccharide Polymers 0.000 claims description 11
- 239000005017 polysaccharide Substances 0.000 claims description 11
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 10
- 241000194020 Streptococcus thermophilus Species 0.000 claims description 10
- 229920000642 polymer Polymers 0.000 claims description 10
- 239000007779 soft material Substances 0.000 claims description 10
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 9
- 230000000415 inactivating effect Effects 0.000 claims description 9
- 241000195493 Cryptophyta Species 0.000 claims description 8
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 8
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 7
- 244000199885 Lactobacillus bulgaricus Species 0.000 claims description 7
- 235000013960 Lactobacillus bulgaricus Nutrition 0.000 claims description 7
- 239000008103 glucose Substances 0.000 claims description 7
- 150000004676 glycans Chemical class 0.000 claims description 7
- 229940004208 lactobacillus bulgaricus Drugs 0.000 claims description 7
- 239000006188 syrup Substances 0.000 claims description 7
- 235000020357 syrup Nutrition 0.000 claims description 7
- 241000233866 Fungi Species 0.000 claims description 6
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 6
- 239000003795 chemical substances by application Substances 0.000 claims description 6
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 claims description 6
- 239000002253 acid Substances 0.000 claims description 5
- 239000004310 lactic acid Substances 0.000 claims description 4
- 235000014655 lactic acid Nutrition 0.000 claims description 4
- 108091005804 Peptidases Proteins 0.000 claims description 3
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims description 3
- 229930006000 Sucrose Natural products 0.000 claims description 3
- 239000004615 ingredient Substances 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims description 3
- 239000005720 sucrose Substances 0.000 claims description 3
- 239000004365 Protease Substances 0.000 claims description 2
- 230000002378 acidificating effect Effects 0.000 claims description 2
- 239000003963 antioxidant agent Substances 0.000 claims description 2
- 230000003078 antioxidant effect Effects 0.000 claims description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 2
- 238000004040 coloring Methods 0.000 claims description 2
- 150000002016 disaccharides Chemical class 0.000 claims description 2
- 239000008157 edible vegetable oil Substances 0.000 claims description 2
- 239000003995 emulsifying agent Substances 0.000 claims description 2
- 239000000796 flavoring agent Substances 0.000 claims description 2
- 235000013355 food flavoring agent Nutrition 0.000 claims description 2
- 150000002772 monosaccharides Chemical class 0.000 claims description 2
- 125000000185 sucrose group Chemical group 0.000 claims description 2
- 102000018697 Membrane Proteins Human genes 0.000 claims 1
- 108010052285 Membrane Proteins Proteins 0.000 claims 1
- 210000004027 cell Anatomy 0.000 description 90
- 229920002774 Maltodextrin Polymers 0.000 description 86
- 239000005913 Maltodextrin Substances 0.000 description 86
- 229940035034 maltodextrin Drugs 0.000 description 86
- 239000000499 gel Substances 0.000 description 72
- 239000000243 solution Substances 0.000 description 55
- 239000012071 phase Substances 0.000 description 48
- 238000001218 confocal laser scanning microscopy Methods 0.000 description 44
- 239000000523 sample Substances 0.000 description 40
- 238000005191 phase separation Methods 0.000 description 37
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 37
- 235000013305 food Nutrition 0.000 description 24
- 239000013049 sediment Substances 0.000 description 21
- 238000005119 centrifugation Methods 0.000 description 18
- 241000186660 Lactobacillus Species 0.000 description 17
- 229940039696 lactobacillus Drugs 0.000 description 17
- 239000000839 emulsion Substances 0.000 description 16
- 238000005259 measurement Methods 0.000 description 16
- 239000011521 glass Substances 0.000 description 14
- 230000003993 interaction Effects 0.000 description 14
- 230000036962 time dependent Effects 0.000 description 13
- 239000006228 supernatant Substances 0.000 description 11
- 239000000463 material Substances 0.000 description 10
- 235000018102 proteins Nutrition 0.000 description 10
- 102000004169 proteins and genes Human genes 0.000 description 10
- 108090000623 proteins and genes Proteins 0.000 description 10
- 239000006185 dispersion Substances 0.000 description 9
- 239000000945 filler Substances 0.000 description 9
- 239000000725 suspension Substances 0.000 description 9
- 238000007669 thermal treatment Methods 0.000 description 9
- 239000007788 liquid Substances 0.000 description 8
- 239000011159 matrix material Substances 0.000 description 8
- 238000000518 rheometry Methods 0.000 description 8
- 238000011282 treatment Methods 0.000 description 8
- 238000009736 wetting Methods 0.000 description 8
- 230000004075 alteration Effects 0.000 description 7
- 239000013068 control sample Substances 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 238000005538 encapsulation Methods 0.000 description 7
- 239000007787 solid Substances 0.000 description 7
- 210000005253 yeast cell Anatomy 0.000 description 7
- 230000008859 change Effects 0.000 description 6
- 238000010348 incorporation Methods 0.000 description 6
- 229920002959 polymer blend Polymers 0.000 description 6
- 239000012153 distilled water Substances 0.000 description 5
- 239000000416 hydrocolloid Substances 0.000 description 5
- 238000012552 review Methods 0.000 description 5
- 229920001202 Inulin Polymers 0.000 description 4
- 150000007514 bases Chemical class 0.000 description 4
- 239000006285 cell suspension Substances 0.000 description 4
- 210000002421 cell wall Anatomy 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 239000012530 fluid Substances 0.000 description 4
- 230000002779 inactivation Effects 0.000 description 4
- 229940029339 inulin Drugs 0.000 description 4
- 239000004006 olive oil Substances 0.000 description 4
- 235000008390 olive oil Nutrition 0.000 description 4
- 230000003534 oscillatory effect Effects 0.000 description 4
- 238000003860 storage Methods 0.000 description 4
- 150000007513 acids Chemical class 0.000 description 3
- 150000001720 carbohydrates Chemical group 0.000 description 3
- 239000000084 colloidal system Substances 0.000 description 3
- 230000002255 enzymatic effect Effects 0.000 description 3
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 3
- 239000007791 liquid phase Substances 0.000 description 3
- 238000001000 micrograph Methods 0.000 description 3
- 230000006911 nucleation Effects 0.000 description 3
- 238000010899 nucleation Methods 0.000 description 3
- 230000037361 pathway Effects 0.000 description 3
- 229920001592 potato starch Polymers 0.000 description 3
- 238000001179 sorption measurement Methods 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- KUVIULQEHSCUHY-XYWKZLDCSA-N Beclometasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(Cl)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)COC(=O)CC)(OC(=O)CC)[C@@]1(C)C[C@@H]2O KUVIULQEHSCUHY-XYWKZLDCSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical group C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- MSFSPUZXLOGKHJ-UHFFFAOYSA-N Muraminsaeure Natural products OC(=O)C(C)OC1C(N)C(O)OC(CO)C1O MSFSPUZXLOGKHJ-UHFFFAOYSA-N 0.000 description 2
- 108010013639 Peptidoglycan Proteins 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000008878 coupling Effects 0.000 description 2
- 238000010168 coupling process Methods 0.000 description 2
- 238000005859 coupling reaction Methods 0.000 description 2
- 230000009849 deactivation Effects 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 2
- 239000003094 microcapsule Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 239000003607 modifier Substances 0.000 description 2
- 239000002105 nanoparticle Substances 0.000 description 2
- 239000002417 nutraceutical Substances 0.000 description 2
- 235000021436 nutraceutical agent Nutrition 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 239000008188 pellet Substances 0.000 description 2
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 239000012266 salt solution Substances 0.000 description 2
- 229920006395 saturated elastomer Chemical class 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 238000001330 spinodal decomposition reaction Methods 0.000 description 2
- 101150008563 spir gene Proteins 0.000 description 2
- 239000010409 thin film Substances 0.000 description 2
- 230000001052 transient effect Effects 0.000 description 2
- 239000011800 void material Substances 0.000 description 2
- 238000003260 vortexing Methods 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 description 1
- 239000002028 Biomass Substances 0.000 description 1
- 241000168525 Haematococcus Species 0.000 description 1
- 102100024023 Histone PARylation factor 1 Human genes 0.000 description 1
- 101001047783 Homo sapiens Histone PARylation factor 1 Proteins 0.000 description 1
- 241000186605 Lactobacillus paracasei Species 0.000 description 1
- 241000183024 Populus tremula Species 0.000 description 1
- 239000005708 Sodium hypochlorite Substances 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 108010046377 Whey Proteins Proteins 0.000 description 1
- 102000007544 Whey Proteins Human genes 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 239000003905 agrochemical Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000004581 coalescence Methods 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 235000008504 concentrate Nutrition 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 230000005493 condensed matter Effects 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 238000004624 confocal microscopy Methods 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000000295 emission spectrum Methods 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 238000001215 fluorescent labelling Methods 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 239000005417 food ingredient Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 229960002442 glucosamine Drugs 0.000 description 1
- JEGUKCSWCFPDGT-UHFFFAOYSA-N h2o hydrate Chemical compound O.O JEGUKCSWCFPDGT-UHFFFAOYSA-N 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000004973 liquid crystal related substance Substances 0.000 description 1
- 230000002535 lyotropic effect Effects 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 239000008204 material by function Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 239000004530 micro-emulsion Substances 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 239000006041 probiotic Substances 0.000 description 1
- 230000000529 probiotic effect Effects 0.000 description 1
- 235000018291 probiotics Nutrition 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000008707 rearrangement Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000002787 reinforcement Effects 0.000 description 1
- 239000006254 rheological additive Substances 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 238000004611 spectroscopical analysis Methods 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 238000005482 strain hardening Methods 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
- 238000002525 ultrasonication Methods 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 235000021119 whey protein Nutrition 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L89/00—Compositions of proteins; Compositions of derivatives thereof
- C08L89/04—Products derived from waste materials, e.g. horn, hoof or hair
- C08L89/06—Products derived from waste materials, e.g. horn, hoof or hair derived from leather or skin, e.g. gelatin
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B30/00—Preparation of starch, degraded or non-chemically modified starch, amylose, or amylopectin
- C08B30/12—Degraded, destructured or non-chemically modified starch, e.g. mechanically, enzymatically or by irradiation; Bleaching of starch
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B31/00—Preparation of derivatives of starch
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08H—DERIVATIVES OF NATURAL MACROMOLECULAR COMPOUNDS
- C08H1/00—Macromolecular products derived from proteins
- C08H1/06—Macromolecular products derived from proteins derived from horn, hoofs, hair, skin or leather
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L3/00—Compositions of starch, amylose or amylopectin or of their derivatives or degradation products
- C08L3/02—Starch; Degradation products thereof, e.g. dextrin
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L3/00—Compositions of starch, amylose or amylopectin or of their derivatives or degradation products
- C08L3/04—Starch derivatives, e.g. crosslinked derivatives
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/12—Unicellular algae; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/14—Fungi; Culture media therefor
- C12N1/16—Yeasts; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/36—Adaptation or attenuation of cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/04—Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
Definitions
- Biopolymer Compositions Comprising a Plurality of Treated Single-Celled Microorganisms
- This invention relates to biopolymer compositions modified by a plurality of treated single- celled microorganisms wherein at least one single-celled microorganism has been substantially inactivated and comprises at least one surface-altered property.
- thermodynamic incompatible biopolymers A phase-separated solution of thermodynamic incompatible biopolymers is known as a water-in-water emulsion (Tolstoguzov, V. B. (1998). Functional properties of protein- polysaccharide mixtures. In S. E. Hill, D. A. Ledward, & J. R. Mitchell (Eds.), Functional properties of food macromolecules (2 nd ed) (pp. 252-277). Gaithersburg, MD: Aspen Publishers). The stability of such a system can be addressed by conventional emulsion theories (Foster, T. J., Underdown, J., Brown, C. R., Gustavo, D. P., & Norton, I. T. (1997).
- phase-separating system the incompatible components try to minimize their contact to decrease an unfavorable interaction.
- introducing a third component into the system can minimise the contact between the two original phases, and if one of the original components completely wets the newly introduced third component, the phase separation condition is altered (Cahn, J. W. (1977). Critical-point wetting. Journal of Chemical Physics, 66, 3667-3672).
- Tanaka and co-workers Tanaka, H., Lovinger, A. J., & Davis, D. D. (1994). Pattern evolution caused by dynamic coupling between wetting and phase-separation in binary-liquid mixture containing glass particles.
- this phase preferentially wets and includes most of the particles within itself.
- a layer of wetting fluid surrounds the particles (Araki, T., & Tanaka, H. (2008). Dynamic depletion attraction between colloids suspended in a phase-separating binary liquid mixture. Journal of Physics- Condensed Matter, 20, 072101) and the attractive phase absorbs more particles as the phase separation proceeds (Tanaka, H., Lovinger, A. J., & Davis, D. D. (1994). Pattern evolution caused by dynamic coupling between wetting and phase-separation in binary-liquid mixture containing glass particles. Physical Review Letters, 72, 2581-2584; Karim, A., Douglas, J.
- the formed shield isolates the substance from its surrounding (Zuidam, N. J. & Shimoni, E. (2010). Overview of microencapsulates for use in food products or processes and methods to make them.
- Zuidam, N. J. & Nedovic, V. (Eds.) Encapsulation technologies for active food ingredients and food processing. New York, USA, Springer, (pp. 3-29)
- acts as a protective barrier preserves the entrapped substance against undesirable physiochemical changes.
- Encapsulation may be triggered spontaneously by thermodynamic incompatibility between biopolymers solutions and liquid-liquid phase separation. As the phase separation progresses, the solubility of each biopolymer is reduced and each biopolymer concentrates into a separate domain.
- deposition of the cells (particles) on the protein-polysaccharide interface can provide an extra protective shield around the formed domains and it can enhance the encapsulation process further.
- Accumulation of probiotic bacteria (e.g., Lactobacillus paracasei) on dextran- methylcellulose interface, (polysaccharide-polysaccharide interface) as a means of new encapsulation material has been reported earlier (Poortinga, A. T. (2008). Microcapsules from self-assembled colloidal particles using aqueous phase-separated polymer solutions. Langmuir, 24, 1644-1647).
- Novel foods with microalgal ingredients Effect of gel setting conditions on the linear viscoelasticity of Spirulina and Haematococcus gels. Journal of Food Engineering, 110, 182- 189; Batista, A. P.; Nunes, M. C; Raymundo, A.; Gouveia, L.; Sousa, I.; Cordobes, F.; Guerrero, A. & Franco, J. M. (201 1). Microalgae biomass interaction in biopolymer gelled systems. Food Hydrocolloids, 25, 817-825). Incorporation of an active filler reinforces mechanical strength of the gel (Yost, R. A. & insella, J. E. (1992).
- G" shear loss modulus
- G* complex shear modulus
- biopolymer refers to a polymer that is produced by a living organism.
- altered surface property refers to at least one single-celled microorganism with at least one altered cell surface property.
- the term "treated” refers to the altering, preferably substantially inactivating, of at least one characteristic of a single-celled microorganism using means such as, but not limited to, chemical, thermal, biochemical and radiation.
- the treatment comprises contacting the single-celled microorganism with at least one substance that results in substantial inactivation and preferably alteration of the surface of the microorganism, and/or an alcohol, or a combination thereof.
- the at least one substance is selected from a basic compound or a salt, or the like.
- the basic compound is preferably an alkali metal hydroxide, most preferably sodium hydroxide, or the like.
- the salt is preferably a sodium or potassium salt, most preferably sodium chloride.
- the at least one substance is an enzyme preferably a protease, or the like.
- the at least one substance is an acid preferably hydrochloric acid, or the like.
- the alcohol is preferably selected from the group consisting of methanol, ethanol, n-propanol and isopropanol, or the like, most preferably ethanol.
- substantially inactivated refers to a single-celled microorganism that is no longer viable.
- soft material refers to a polymer, a biopolymer or a mixture of polymers or biopolymers thereof
- biopolymer solution refers to a dispersion, suspension or solution of at least one biopolymer or mixture of biopolymers.
- biopolymer solution refers to a dispersion, suspension or solution of at least one biopolymer or mixture of biopolymers.
- a process for treating at least one single- celled microorganism, preferably a plurality of single-celled microorganisms, resulting in at least one substantially inactivated single cell microorganism with at least one altered surface property comprising:
- a use of a plurality of single-celled microorganisms comprising at least one substantially inactivated single cell microorganism with at least one altered surface property, in altering at least one property of a soft material.
- the soft material may be a biopolymer.
- the biopolymer may be a protein or polysaccharide, such as gelatin, starch, or starch-derived material.
- a soft material comprising a plurality of substantially inactivated single-celled microorganisms with at least one altered surface property.
- said microorganisms are present in said soft material between about 0.1% and about 30% by weight, preferably between about 0.5% and about 10% by weight and most preferably between about 1% and about 5% by weight.
- the single-celled microorganism is selected from the group consisting of fungi, algae and bacteria.
- the fungi are most preferably a yeast such as Saccharomyces cerevisiae.
- the algae are most preferably chlorella or spirulina.
- the bacteria are most preferably selected from lactic acid bacteria, preferably Lactobacillus bulgaricus and/or Streptococcus thermophilus.
- the at least one altered surface property of the single-celled microorganisms comprises denaturation of proteins on the cell wall, preferably selected from denaturing mannoprotein in a yeast cell wall ⁇ Saccharomyces cerevisiae) denaturing peptidoglycan in a spirulina cell wall, denaturing glucosamine in a chlorella cell wall and denaturing peptidoglycan in a Lactobacillus bulgaricus or Streptococcus thermophilus cell wall.
- the substantially inactivating step and the substantially altering step may occur simultaneously or sequentially, preferably simultaneously.
- the substantially inactivating step involves the use of at least one of a substance, heat, microwave, ultraviolet light or irradiation or a combination thereof.
- the substantially inactivating and/or substantially altering steps are carried out by contacting the single-celled microorganism with at least one substance selected from an enzyme, a basic substance, an acidic substance or an alcohol or a combination thereof, preferably at a predetermined temperature.
- the single-celled microorganisms are substantially inactivated and substantially altered by this process.
- the treated single-celled microorganisms are subjected to a washing step.
- microorganisms and optionally with said at least one sweetener.
- the biopolymer is in the form of a biopolymer solution which contains about 0.1 % to about 30% by weight of biopolymer, preferably about 1 % to about 20%) by weight of biopolymer and most preferably about 3% to about 15% by weight of biopolymer.
- the biopolymer is a protein, polysaccharide or a combination thereof, most preferably the biopolymer is gelatin, starch or a starch-based material.
- the sweetener is present in an amount of about 0% to about 60% by weight, preferably about 50% by weight.
- the sweetener may be crystalline, noncrystalline or glassy in form, in another embodiment, the sweetener may be in a solid or a liquid form.
- the sweetener is selected from saccharides, said saccharides are selected from monosaccharides, disaccharides or polysaccharides, derivatives and/or modified forms thereof.
- said sweeteners are selected from combinations thereof.
- the sweetener is sucrose or glucose syrup or combinations thereof.
- the biopolymer solution may further comprise at least one flavouring agent. In yet another embodiment, the biopolymer solution may further comprise at least one colouring agent. In another embodiment, the biopolymer solution may further comprise at least one acidulant. In another embodiment, the biopolymer solution may further comprise at least one salt. In another embodiment, the biopolymer solution may further comprise at least one antioxidant. In another embodiment, the biopolymer solution may further comprise at least one edible oil. In another embodiment, the biopolymer solution may further comprise at least one emulsifier. In another embodiment, the biopolymer solution may further comprise at least one glazing agent. In another embodiment, the biopolymer solution may further comprise at least one vitamin.
- the biopolymer solution may further comprise at least one lipophilic agent. In another embodiment, the biopolymer solution may further comprise at least one mineral. Further and other ingredients known in the food industry to a person of ordinary skill in the art may be added to the biopolymer solution without compromising the present invention.
- substantially inactivating a plurality of single-celled microorganisms results in and alteration of the rheological property of the biopolymer solution.
- said treated plurality of single-celled microorganisms of the present invention as a food-grade colloidal particle.
- a texture modifier for example as precursors for developing microstructures, and as interfacial particles for encapsulation of small molecules, including but not limited to pharmaceuticals, nutraceuticals, agrochemicals, health supplements, personal health care products and cosmetics.
- a structure modifier for example as precursors for developing microstructures, and as interfacial particles for encapsulation of small molecules, including but not limited to pharmaceuticals, nutraceuticals, agrochemicals, health supplements, personal health care products and cosmetics.
- a a plurality of treated single-celled microorganisms comprising at least one substantially inactivated single-celled microorganism wherein said microorganism further comprises at least one altered surface property.
- the single-celled microorganisms are most preferably selected from yeast, algae and bacteria.
- the algae are chlorella and spirulina
- the bacteria are selected from lactic acid bacteria, for example, Lactobacillus bulgaricus or Streptococcus thermophilus
- the yeast are selected from Saccharomyces cerevisiae
- Preparation of the substantially inactivated single-celled microorganism preferably involves contacting the microorganism with at least one substance resulting in substantial inactivation and preferably alteration of the surface of the single-celled microorganism, selected from a basic compound, an acidic compound, a salt, and an alcohol at a predetermined temperature.
- the basic substance is preferably an alkali metal hydroxide, most preferably sodium hydroxide.
- the acidic compound is preferably hydrochloric acid, or the like.
- the salt is preferably a sodium or potassium salt, most preferably sodium chloride.
- the predetermined temperature at which the inactivation process may be carried out is preferably between about 70°C and about 1 10°C, more preferably between about 80°C and 100°C and most preferably about 95 °C.
- the duration of the inactivation process may be about 20 minutes with optional agitation every about 5 to about 7 minutes.
- the substance when the substance is a basic compound, an acidic compound or a salt, the substance substantially inactivates and substantially alters the surface of the single-celled microorganism.
- the substance when the substance is an alcohol selected from the group consisting of methanol, ethanol, n-propanol and isopropanol, most preferably ethanol, the predetermined temperature at which alteration of the surface is preferably between about 15°C and about 60°C, more preferably between about 20°C and 50°C and most preferably between about 25°C and 45°C.
- the duration of the alteration process may be between about 12 hours and six days, most preferably between about 16 hours and five days.
- the treatment comprises: 1) optionally substantially inactivating the single-celled microorganism by means discussed herein; 2) contacting the optionally substantially inactivated single-celled microorganism with at least one enzyme for substantial alteration of the surface of the single-celled microorganism at a predetermined time and temperature from about 35°C to about 65°C resulting in substantial alteration; 3) substantially deactivating, preferably fully deactivating, the at least one enzyme, preferably at a deactivation temperature, more preferably at a deactivation temperature that is dependent on the selected enzyme.
- the treated single-celled microorganisms are preferably washed, preferably with distilled water, to remove base, acid, salt, alcohol and/or enzyme from the treated single-celled microorganisms.
- the biopolymer to be modified is preferably a polypeptide, a protein or polysaccharide, most preferably gelatin, starch or a starch-derived material.
- the formation of a solution of the biopolymer is carried out by dissolving the biopolymer in water at an elevated temperature with mixing.
- the preferred temperature is from about 65°C to about 100°C, preferably from about 80°C to about 100°C and most preferably about 90°C.
- Mixing may be accomplished by any means known to a person of ordinary skill in the art.
- the biopolymer solution further comprises at least one sweetener, preferably a saccharide and most preferably sugar or a glucose syrup or a combination thereof. Further and other aspects of the present invention will become apparent to the person of skill in the art.
- CLSM confocal laser scanning microscopy
- Loss modulus (G) is adjacent to X axis
- G" is adjacent to X axis
- Figure 21 is a I %
- G" is adjacent to X axis.
- G" is adjacent to X axis.
- G" is adjacent to X axis.
- Cells 30 reside on the interface and associate with the gelatin phase 32, and the gelatin forms continuous structures seemingly out of equilibrium.
- the phase separation proceeds further when the sample is kept at 40 °C for 10 minutes, with the microstructure reaching an apparent degree of equilibrium.
- the coarsened, cell-coated gelatin droplets 40 in the sample merged into a continuous gelatin phase, and some of them formed larger droplets with extended features.
- Maltodextrin-rich regions 42 appeared as void regions depleted of gelatin and cells.
- Gelatin-rich domains manifested a high accumulation of cells in the form of clusters, but some dark (maltodextrin-rich) patches also existed in cell clusters within these gelatin-rich domains.
- cells were associated with the gelatin phase 50 and built up a continuous phase.
- Maltodextrin forms included phases in the shape of individual droplets 52 (dark circles). This microstructure indicates that phase separation proceeded through nucleation and growth.
- cells were not associated with the interface, and maltodextrin regions at the interface resemble void regions with blunt edges.
- the microstructure displays bicontinuous features, with cells associated mostly with the gelatin phase 70.
- the lack of any round droplets in the microstructure suggests that the pathway of phase separation was spinodal decomposition without secondary phase separation.
- the presence of cells in the system profoundly affects the microstructure: the interface boundaries are not smooth and do not possess a curvature similar to conventional spinodal- type microstructures. On the contrary, the interface boundaries are rather linear and jagged. The alignment of the cells on the interface influenced this interface morphology.
- the domains exhibit more expansion due to additional coarsening caused by this longer thermal treatment.
- the bicontinuous structure and interfacial features of the phase boundaries of the microstructure were preserved; i.e., they remained more or less linear and jagged.
- the domains 80 had irregular spacing distances, and some edges of the gelatin-rich domains 82 appeared narrow and starched. These are the regions where gelatin defused inside the domains, and cells on the interface formed ductile-type features.
- the microstructure of gelatin-maltodextrin gels containing spirulina 90 is fairly similar to that of gelatin-maltodextrin gels containing chlorella. However, the number and size of maltodextrin-rich domains 92 in the sample containing spirulina appeared lower than those of the sample containing chlorella.
- the microstructure of gelatin-maltodextrin gels containing spirulina held for this length of time resembled their counterpart sample containing chlorella, except that the size and number of maltodextrin-rich domains - in the form of partial crescents and incomplete circles - were smaller than those in the sample containing chlorella.
- the size and number of maltodextrin-rich droplet-like features 100 (included phase) within the gelatin-rich domains 102 appear higher than those in the sample containing chlorella.
- the addition of lwt% salt to gelatin-maltodextrin gels under this thermal treatment significantly enhanced the extent of phase separation.
- Some maltodextrin-rich droplets 1 10 appeared larger than those in samples without salt ( Figures land 2 above), and the presence of larger gelatin droplets within the maltodextrin-rich droplets 1 10 indicated that secondary phase separation had also progressed further.
- the addition of salt to the gelatin-maltodextrin gel containing chlorella caused drastic changes in the system microstructure, such as phase inversion and the adsorption of cells on the gelatin-maltodextrin interface.
- cells associated with the gelatin phase 120 were similar to those in the system without salt.
- the continuous gelatin phase transformed into a discontinuous phase, forming individual gelatin droplets 120 scattered in a maltodextrin continuous phase 122.
- a very distinctive feature of the microstructure is the association of the cells with interfacial regions. As we can clearly see, cells 130, 132 are adsorbed at the interface.
- the microstructure well-represents a water-in-water emulsion, consisting of a continuous maltodextrin-rich phase 134 and flocculated droplets of a gelatin- rich phase 136.
- the addition of salt to a gelatin-maltodextrin gel containing spirulina caused immense changes in system microstructure.
- the phase separation pathway form nucleation and growth changed to spinodal decomposition, and consequently the microstructure transformed from droplets and a continuous matrix to a semi-bicontinuous microstructure.
- the gelatin-rich phase 140 constructs the continuous phase, and the maltodextrin-rich phase 142 forms non-spherical blobs as an included phase.
- cells normally associated with the gelatin-rich phase were adsorbed at the gelatin-maltodextrin interface 144.
- the modified biopolymers of the present invention can be subjected to rheological measurements, preferably small-deformation oscillatory measurements to demonstrate the improved characteristics of the biopolymers modified by the plurality of inactivated single- celled microorganism.
- Measurement of storage modulus (G') and loss modulus (G") of phase-separated biopolymer gels may be carried out at about 25°C.
- time-dependent G' and G" of phase-separated gels at 25 °C illustrating samples containing single cell microorganisms as well as a control sample without added cells.
- time-dependent G' and G" of phase-separated gels at 25 °C consisting of samples containing single cell microorganisms and one control sample without added cells (each held at 40 °C for 10 min).
- all samples containing single cell organisms (2wt%) showed higher G' than that of samples without added cells.
- the gelatin plus maltodextrin system showed the lowest G' after 1 hour (648.6 ⁇ 12 A Pa).
- Lactobacillus G' increased 42.34 ⁇ 0.1 % to 923.3 ⁇ 30 Pa.
- chlorella G' increased 104% to 1323 ⁇ 40.41 Pa.
- the addition of yeast caused a 155.3%) increase in G' to 1656.6 ⁇ 41.6 Pa, and the incorporation of spirulina caused a 215 % increase in G' to 2043.3 ⁇ 70.9 Pa.
- time-dependent G' and G" of phase-separated gels at 25 °C illustrating three samples - one containing 2wt% chlorella, one with 2wt% spirulina, and a control sample without added cells - in the presence of lwt% salt (NaCl).
- CLSM micrographs show phase- separated samples encapsulating 1 wt% olive oil 160, 162 within discontinuous 3 wt% gelatin phase 164 scattered in a 10 wt%. maltodextrin continuous phase 166. Gelatin domains are encapsulated with substantially inactivated 1 wt% yeast 168, 169 (by 1 M solution of NaOH).
- micrographs demonstrate partitioning of the particles (spirulina) and oil droplets in the dispersed gelatin phase due to liquid-liquid phase separation. Since this encapsulation method does not require organic solvents or other chemicals, sensitive substances like cells and vulnerable lipophilic agents can be preserved within the phase-separated domains with the extra protection of the absorbed particles (yeast cells) at the liquid-liquid interface.
- time-dependent G' and G" of gelatin-only gels (single phase, containing one biopolymer) at 25 °C, illustrate samples containing single cell microorganisms as well as a control sample without added cells.
- the gelatin without added cells system showed the lowest G' after 1 hour (447 ⁇ 8 Pa).
- systems containing added single cells (2wt%) showed higher G' than that of the sample without added cells.
- G' increased 58.2 % to 707.3 ⁇ 20 Pa.
- G' was raised by 64.7 % to 736.3 ⁇ 22.8 Pa.
- the addition of yeast caused a 1 1 1.5% increase in G' to 945.6 ⁇ 17 Pa.
- the incorporation of spirulina caused a pronounced 155.7 % increase in G', to 1 143.3 ⁇ 55 Pa.
- time-dependent G' and G" of gelatin-inulin gels illustrate samples containing single cell microorganisms as well as a control sample without added cells.
- the G' of gelatin-inulin sample without added cells reached to 261.3 ⁇ 1 1.54 Pa after 1 hour.
- systems containing added single cells (2wt%) showed higher G' than that of the sample without added cells.
- Streptococcus thermophilus G' increased 69.5 % to 443 ⁇ 7 Pa.
- time-dependent G' and G" of gelatin 6 wt% and starch 6 wt% and sugar 20 wt% and glucose syrup 30 wt% gels at 25 °C illustrate samples containing single cell microorganisms as well as a control sample without added cells.
- the G' of gelatin/starch/sugar/glucose syrup sample without added cells reached to 3573.3 ⁇ 87.3 Pa after 1 hour.
- Strain-sweep tests at a constant frequency may be carried out on the modified biopolymer solutions to assess viscoelastic properties of the modified biopolymer.
- the changes in complex shear modulus (G*) as a function of shear strain amplitude in the oscillatory mode were monitored.
- the initial G*of each sample matched its G' valve. Results showed that all samples had a long linear viscoelastic region.
- Samples containing 2wt% Lactobacillus showed strain- softening behaviour (decreasing the G* under strain); samples containing 2wt% spirulina and 2wt% yeast displayed similar behaviour, but to a lower extent with spirulina and even more moderately in the sample containing yeast.
- increasing the strain to approximately 1-2.5 (100-250%) fractured the sample on the macroscopic scale, causing a more than 5% decrease in the initial value of G*.
- all samples showed strain hardening behaviour, becoming resistant to flow under greater deformation.
- phase separation dictates the microstructure morphologies in a thermodynamic-incompatible biopolymer solution.
- gelatin-maltodextrin gel is considered a filled gel and, depending on the continuous and included phase, it could be classified as a gelatin gel filled with a maltodextrin included phase or vice versa.
- the addition of a plurality of treated single-celled microorganisms to a phase-separated gelatin-maltodextrin gel significantly alters the developing microstructures under phase separation conditions.
- the single-celled microorganisms as colloidal particles, it is possible to create a group of microstructures that never existed before.
- the presence of a plurality of treated single-celled microorganism enhances the rheological properties of the phase-separated gel. It can also enhance the G' of the gel and, more importantly, it reduces the negative impact of phase separation on G'. Most likely, as the biopolymer-cell forms stiffer chains, the resulting gel becomes more resistance to rheological changes induced by phase separation.
- Treated single-celled microorganisms can be used as colloidal particles in thermodynamic-incompatible biopolymer solutions, or thermodynamic-compatible biopolymer solutions or in biopolymer solutions as filler particles.
- Different groups of treated single-celled microorganisms create different types of microstructures and impart different rheological properties to the mixture.
- These treated cell-incorporated biopolymers emulsions (“cibe") could be considered as an addition to food gels, providing diverse microstructures and enhanced rheological properties.
- Non-limiting examples are provided as follows.
- Streptococcus thermophilus ST-M5 in the form of freeze-dried pellets were supplied from Chr. Hansen (Milwaukee, WI, USA).
- Protease enzyme Protin NY 100, was kindly supplied by Amano Enzyme INC (Nagoya, Japan).
- Hydrochloric acid A.C.S. 36.5-38% was supplied by Fisher Scientific (Ottawa, ON, Canada).
- Sucrose sucrose (sugar) was provided by Sigma-Aldrich (Oakville, ON, Canada).
- Single-celled microorganisms were treated with NaOH, HC1, saturated salt solution, enzyme or alcohol solutions. After treatment the single-celled microorganisms were washed repeatedly with distilled water until soluble substances substantially extracted from the cells and centrifugation of cell/distilled water dispersion resulted in a substantially clear and transparent supernatant (water) and homogenous and uniform sediment (cells). After washing pH was adjusted to 7 ⁇ 0.2 for cells treated with NaOH or HC1. Moisture (water content) of all prepared cells was adjusted to 89-95 wt% by measuring the solid contents of the dispersion of each prepared cell by means of water evaporations at 50 °C using a thermostat controlled oven. The electric charge of the cells and zeta potential ( ⁇ ) were measured with a 90 PlusTM particle size analyzer provided by Brookhaven Instruments Corporation (Holtsville, USA).
- Yeast cells were suspended in a 1 M solution of NaOH at a concentration of 10 wt% in a sealed screw cap glass bottle.
- the yeast-containing bottle was placed in water bath at 95 °C for 20 min and it was shaken regularly every 5-6 min for 15-20 sec. Then, the glass bottle was removed from the water bath and left at room temperature to sediment the undissolved fraction of yeast cells from the solution. The supernatant was discarded and each 15 ml of sediment was transferred to a 50 ml centrifuge tube and washed 7-9 times with 30 ml of water by repeated re-suspension/centrifugation cycles (5 min, 3000 rpm).
- Chlorella cells were suspended in a saturated salt solution with a concentration of 10 wt% in a sealed screw cap glass bottle.
- the Chlorella-containing bottle was placed in a water bath at 95 °C for 20 min and it was shaken regularly every 5-6 min for 15-20 sec. Then, the glass bottle was removed from the water bath and left at room temperature to sediment the chlorella cells from the solution. The supernatant was discarded and the sediment was mixed with an equal volume of 50% (v/v) ethanol solution. The mixture was kept in a sealed glass bottle for 5 days at 45 °C in a thermostat-controlled oven.
- Lactobacillus cells in the form of frozen pallets were thawed and transferred to a 50 ml centrifuge tube and kept in a water bath at 95 °C for 20 min followed by centrifugation for 15 min at 3000 rpm. Then, supernatant and solid sediments were separated from cell dispersions. Each 15-20 ml of cell dispersion was transferred to a 50 ml centrifuge tube and washed 4-5 times with 30 ml water by repeated re-suspension/centrifugation cycles (15 min, 3000 rpm). After each stage of centrifugation, the solid, cake-like sediment at the bottom of the sediment in the centrifuge tubes was discarded.
- the gelatin and maltodextrin solutions were prepared in separate, sealed, screw-cap glass vials (20 ml) by placing them in a 90 °C water bath for 10 min for maltodextrin and for 3 min for the gelatin solution, with vortexing at 10-15 sec intervals at 3000 rpm (Fisher Scientific, Nepean, ON, Canada).
- the cell suspension was added to the gelatin-containing vial and vortexed as above.
- solutions of twice the required final biopolymer concentrations were prepared and mixed with equal weights of the biopolymer solutions.
- the final blends were mixed at « 90 °C and again placed in a water bath at « 90 °C for 1-2 min with repeated vortexing.
- the gelatin solution also contained ⁇ 0.001 wt % FITC.
- a Physica MCR 301 rheometer (Anton Paar GmbH, Graz, Austria), equipped with a Peltier plate temperature control unit (P-PTD 200), was used to perform small-deformation oscillatory rheometery. All measurements were carried out with parallel plate geometry (PP 25/TG) with a diameter of 25mm. The time-dependent storage (G') and loss moduli (G") were measured at 25 °C at a constant frequency of 1 Hz and a target strain of 0.2% for up to 70 min. To avoid sample drying, the measuring geometry was covered with a solvent trap containing a moist strip of tissue paper.
- the temperature of the Peltier plate was set at 40 °C and the mixed hot biopolymer solution (at 90 °C) was poured directly onto the hot plate. The geometry was then lowered onto the sample to an operating gap width (1 mm) and the sample was carefully trimmed and held at 40 °C temperature of holding (T h ) for 2 different holding times (3 ⁇ 4) of 30 seconds and 10 minutes to initiate and increase the extent of phase separation. After thermal treatments at 40 °C, the temperature of the rheometer cell was decreased from 40 °C to 25 °C at 16 °C min "1 , and the sample was kept for 1 minute at 25 °C to ensure the equilibrium. At this point, measurements were commenced and lasted for 1 hr.
- Confocal microscopy was performed using an upright Zeiss LSM 510 (Carl Zeiss, Toronto, ON, Canada).
- the CLSM was operated in fluorescent mode with an Ar laser source (488 nm).
- the emission spectra were collected with 1 channel set at 505 nm.
- No fluorescent labeling was used for cell-containing samples, since autofluorescence properties of the cell were sufficient for CLSM observations.
- a flat metal washer with 2 cover slips was used as a sample holder, and the sample was sandwiched within the metallic washer between the 2 cover slips.
- This holder was placed on the Peltier plate temperature control unit of the rheometer, equilibrated, and then samples were processed as per the thermal conditioning used for the rheological measurements. After a 10 min hold at 25 °C, the sample holder was transferred to the CLSM stage for characterization. 10 ⁇ and 20 ⁇ objective lenses were used. Images were recorded at 25 °C at a resolution of 1024 ⁇ 1024 pixels. Image optimization was performed using the LSM 510's built-in image analysis software. Images shown herein are representative of the microstructure seen for a given composition.
- Streptococcus thermophilus cells in the form of freeze-dried pallets were soaked and dispersed by distilled water and transferred to a 50 ml centrifuge tube. Centrifugation for 15 min at 3000 rpm and re-suspension were repeated 4-5 times until the cake-like sediments (remnants of the cell culture) were separated from the cells. Next, hydrochloric acid (32-38% solution) was added to the cell suspensions (around 50 wt% cells) to obtain 1 M acid cell dispersion. The acid-cell solution was transferred to a sealed screw cap glass bottle and placed in a water bath at 95 °C for 20 min and it was shaken regularly every 5-6 min for 15- 20 sec.
- Yeast cells were suspended in a 2 wt% enzyme (Protin NY 100) solution with a concentration of 10 wt% in a sealed screw cap glass bottle.
- the yeast-containing bottle was placed in a thermostat-controlled oven at 45 °C for 24 hours. Then, the glass bottle was removed from the thermostat-controlled oven and it was placed in a water bath at 95 °C for 50 minutes. Then, the glass bottle was removed from the water bath and left at room temperature to sediment the yeast cells from the solution, the supernatant was discarded and each 15 ml of sediment was transferred to a 50 ml centrifuge tube and washed 7-8 times with 30 ml of water by repeated re-suspension/centrifugation cycles (5 min, 3000 rpm).
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- Polymers & Plastics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Materials Engineering (AREA)
- Mycology (AREA)
- Botany (AREA)
- General Chemical & Material Sciences (AREA)
- Cell Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Dermatology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
The present invention relates to a plurality of single-celled microorganisms comprising at least one substantially inactivated single-celled microorganism wherein the at least one substantially inactivated single-celled microorganism further comprises at least one altered surface property, the preparation of these microorganisms and their use in biopolymer compositions.
Description
TITLE OF THE INVENTION
Biopolymer Compositions Comprising a Plurality of Treated Single-Celled Microorganisms
FIELD OF THE INVENTION
This invention relates to biopolymer compositions modified by a plurality of treated single- celled microorganisms wherein at least one single-celled microorganism has been substantially inactivated and comprises at least one surface-altered property.
BACKGROUND OF THE INVENTION
A phase-separated solution of thermodynamic incompatible biopolymers is known as a water-in-water emulsion (Tolstoguzov, V. B. (1998). Functional properties of protein- polysaccharide mixtures. In S. E. Hill, D. A. Ledward, & J. R. Mitchell (Eds.), Functional properties of food macromolecules (2nd ed) (pp. 252-277). Gaithersburg, MD: Aspen Publishers). The stability of such a system can be addressed by conventional emulsion theories (Foster, T. J., Underdown, J., Brown, C. R., Ferdinando, D. P., & Norton, I. T. (1997). Emulsion behavior of non-gelled biopolymer mixtures. In E. Dickinson & B. Bergenstahl (Eds.), Food colloids: Proteins, lipids and polysaccharides (pp. 346-355). Cambridge, UK: Royal Society of Chemistry, Woodhead Publishing Limited). The distinct characteristic of biopolymers emulsion is the extremely low value of its interfacial tension in comparison with that of conventional oil + water emulsions. In biopolymer (water-in-water) emulsions, the interfacial tension between the aqueous phases rich in the two different polymers is remarkably low (Wolf, B., Scirocco, R., Frith, W. J., & Norton, I. T. (2000). Shear-induced anisotropic microstructure in phase-separated biopolymer mixtures. Food Hydrocolloids, 14, 217-225; Scholten, E., Tuinier, R., Tromp, R. H., & Lekkerkerker, H. N.' W. (2002). Interfacial tension of a decomposed biopolymer mixture. Langmuir, 18, 2234- 2238). Therefore, using molecules or particles as interfacial material to produce a water-in- water emulsion raises the question of whether such a system can be emulsified or not (Norton, I. T., Norton, A. B, Spyropoulos, F., Reverend, B. J. D. L., & Cox, P. (201 1). Rheological control and understanding necessary to formulate healthy everyday foods. In I. T. Norton, F. Spyropoulos, & P. Cox (Eds.), Practical food rheology (pp. 219-253).
Chichester, UK: Wiley-Blackwell; Simon, K. A., Sejwal, P., Gerecht, R. B., & Luk, Y.-Y. (2007). Water-in-water emulsions stabilized by non-amphiphilic interactions: Polymer- dispersed lyotropic liquid crystals. Langmuir, 23, 1453-1458; Balakrishnan, G., Nicolai, T., Benyahia, L., & Durand, D. (2012). Particles trapped at the droplet interface in water-in- water emulsions. Langmuir, 28, 5921-5926). However, it has been shown that in a phase- separated water-in-water emulsion, adsorption of colloidal particles at the water-water interface clearly increases the stability of the emulsion (Poortinga, A. T. (2008). Microcapsules from self-assembled colloidal particles using aqueous phase-separated polymer solutions. Langmuir, 24, 1644-1647).
In a phase-separating system, the incompatible components try to minimize their contact to decrease an unfavorable interaction. When a two-phase system of fluids is near its critical point (to phase separate), introducing a third component into the system can minimise the contact between the two original phases, and if one of the original components completely wets the newly introduced third component, the phase separation condition is altered (Cahn, J. W. (1977). Critical-point wetting. Journal of Chemical Physics, 66, 3667-3672). As an example, Tanaka and co-workers (Tanaka, H., Lovinger, A. J., & Davis, D. D. (1994). Pattern evolution caused by dynamic coupling between wetting and phase-separation in binary-liquid mixture containing glass particles. Physical Review Letters, 72, 2581-2584) showed that the addition of glass particles as a third phase to a binary mixture of immiscible liquids affects the phase separation condition and the resulting morphology of the mixture. Tanaka et al. (1994) described this phenomenon as the spatial and shape-pinning effect of particles, which originates from the interplay between the dynamic wetting of the particles and the phase separation in the mixture.
If the added particles have greater attraction toward one of the phases, this phase preferentially wets and includes most of the particles within itself. A layer of wetting fluid surrounds the particles (Araki, T., & Tanaka, H. (2008). Dynamic depletion attraction between colloids suspended in a phase-separating binary liquid mixture. Journal of Physics- Condensed Matter, 20, 072101) and the attractive phase absorbs more particles as the phase separation proceeds (Tanaka, H., Lovinger, A. J., & Davis, D. D. (1994). Pattern evolution caused by dynamic coupling between wetting and phase-separation in binary-liquid mixture containing glass particles. Physical Review Letters, 72, 2581-2584; Karim, A., Douglas, J. F., Nisato, G., Liu, D. W., & Amis, E. J. (1999). Transient target patterns in phase separating
filled polymer blends. Macromolecules, 32, 5917-5924; Lee, B. P., Douglas, J. F., & Glotzer, S. C. (1999). Filler-induced composition waves in phase-separating polymer blends. Physical Review E, 60, 5812-5822; Tanaka, H. (2001). Interplay between wetting and phase separation in binary fluid mixtures: Roles of hydrodynamics. Journal of Physics-Condensed Matter, 13, 4637-4674; Chung, H. J., Taubert, A., Deshmukh, R. D., & Composto, R. J. (2004). Mobile nanoparticles and their effect on phase separation dynamics in thin-film polymer blends. Europhysics Letters, 68, 219-225). The mobility of the particles in an immiscible two-phase liquid system induces a complex dynamic between phase separation and wetting, which can result in various morphologies ( Karim, A., Douglas, J. F., Nisato, G., Liu, D. W., & Amis, E. J. (1999). Transient target patterns in phase separating filled polymer blends. Macromolecules, 32, 5917-5924; Lee, B. P., Douglas, J. F., & Glotzer, S. C. (1999). Filler- induced composition waves in phase-separating polymer blends. Physical Review E, 60, 5812-5822; Tanaka, H. (2001). Interplay between wetting and phase separation in binary fluid mixtures: Roles of hydrodynamics. Journal of Physics-Condensed Matter, 13, 4637- 4674; Chung, H. J., Taubert, A., Deshmukh, R. D., & Composto, R. J. (2004). Mobile nanoparticles and their effect on phase separation dynamics in thin-film polymer blends. Europhysics Letters, 68, 219-225). As the phase separation proceeds, the liquid phase(s) promotes rearrangements of the particles within, but particles can sometimes restrain the phase separation by hindering the coalescence and coarsening of particle-filled domains (Van't Zand, D. D., Schofield, A. B., Thijssen, J. H. J, & Clegg, P. S. (201 1). Hindered coarsening of a phase-separating microemulsion due to dispersed colloidal particles. Langmuir, 27, 13436-13443).
In a phase-separated biopolymer solution, the assembly of colloidal particles at the liquid— liquid interface and at the consequent viscoelastic particle-laden interface has the potential to control and enable the development of a new type of texture for food manufacturing (Foster, T., & Wolf, B. (201 1). Hydrocolloid gums-Their role and interactions in foods. In I. T. Norton, F. Spyropoulos, & P. Cox (Eds.), Practical food rheology: An interpretive approach (pp. 61-84). Chichester, UK: Wiley-Blackwell). However, readily available food-grade colloidal particles are scarce. Production techniques for food-grade particles are restricted by legislative regulations and are limited to small/lab-scale applications. Thus, there has existed a long-felt need for a cost-effective and safe food-grade colloidal particle.
One of the applications of biopolymer mixture is encapsulation (Benichou, A.; Aserin, A. & Garti, N. (2002). Protein-polysaccharide interactions for stabilization of food emulsions. Journal of Dispersion Science and Technology, 23, 93-123; Tolstoguzov, V. B. (2002). Thermodynamic aspects of biopolymer functionality in biological systems, foods, and beverages. Critical Reviews in Biotechnology, 22, 89-174; Dickinson, E. (2003). Hydrocolloids at interfaces and the influence on the properties of dispersed systems. Food Hydrocolloids, 17, 25-39; Tolstoguzov, V. B. (2003). Some thermodynamic considerations in food formulation. Food Hydrocolloids, 17, 1 -23; McClements, D. J. (2006). Non-covalent interactions between proteins and polysaccharides. Biotechnology Advances, 24, 621-625; McClements, D. J.; Decker, E. A.; Park, Y. & Weiss, J. (2009). Structural design principles for delivery of bioactive components in nutraceuticals and functional foods. Critical Reviews in Food Science and Nutrition, 49, 577-606); a process in which an amount of substance is trapped within a shield formed by biopolymer(s). The formed shield isolates the substance from its surrounding (Zuidam, N. J. & Shimoni, E. (2010). Overview of microencapsulates for use in food products or processes and methods to make them. In: Zuidam, N. J. & Nedovic, V. (Eds.) Encapsulation technologies for active food ingredients and food processing. New York, USA, Springer, (pp. 3-29)) and acts as a protective barrier, preserves the entrapped substance against undesirable physiochemical changes. Encapsulation may be triggered spontaneously by thermodynamic incompatibility between biopolymers solutions and liquid-liquid phase separation. As the phase separation progresses, the solubility of each biopolymer is reduced and each biopolymer concentrates into a separate domain. These newly-formed domains can encompass and trap their embedded materials within and, therefore, effectively encapsulate their contained substances (Weiss, J.; Takhistov, P. & Mcclements, D. J. (2006). Functional materials in food nanotechnology. Journal of Food Science, 71, R107-R1 16; Tolstuguzov, V.B. & Rivier, V. (1997). Encapsulated Particles in Protein from a Polysaccharide-Containing Dispersion. European Patent Application, EP 0 797 925 B l . Nestle SA, Vevey, Switzerland). Moreover, deposition of the cells (particles) on the protein-polysaccharide interface can provide an extra protective shield around the formed domains and it can enhance the encapsulation process further. Accumulation of probiotic bacteria (e.g., Lactobacillus paracasei) on dextran- methylcellulose interface, (polysaccharide-polysaccharide interface) as a means of new encapsulation material has been reported earlier (Poortinga, A. T. (2008). Microcapsules
from self-assembled colloidal particles using aqueous phase-separated polymer solutions. Langmuir, 24, 1644-1647).
Single cells performed as active filler particles when added into the gel. Incorporation of active particles in the gel matrix causes an increase in gel modulus (Richardson, R. K.; Robinson, G.; Ross-Murphy, S. B. & Todd, S. (1981). Mechanical spectroscopy of filled gelatin gels. Polymer Bulletin, 4, 541-546; Ring, S. & Stainsby, G. (1982). Filler reinforcement of gels. Progress in Food and Nutrition Science, 6, 323-329; Van Vliet, T. (1988). Rheological properties of filled gels - influence of filler matrix interaction. Colloid and Polymer Science, 266, 518-524). Based on the nonspecific interactions of single cells with the gel matrix and the nature of each group of added cells, we obtained different rheological responses with time/temperature treatments (Th = 40 °C and ¾ = 30 sec and 10 min). In general, it has been reported that single cells of microalgae can act as active and inactive filler particles based on the interaction of microalgae and biopolymers (Batista, A. P.; Nunes, M. C; Fradinho, P.; Gouveia, L.; Sousa, I.; Raymundo, A. & Franco, J. M. (2012). Novel foods with microalgal ingredients - Effect of gel setting conditions on the linear viscoelasticity of Spirulina and Haematococcus gels. Journal of Food Engineering, 110, 182- 189; Batista, A. P.; Nunes, M. C; Raymundo, A.; Gouveia, L.; Sousa, I.; Cordobes, F.; Guerrero, A. & Franco, J. M. (201 1). Microalgae biomass interaction in biopolymer gelled systems. Food Hydrocolloids, 25, 817-825). Incorporation of an active filler reinforces mechanical strength of the gel (Yost, R. A. & insella, J. E. (1992). Microstructure of whey- protein isolate gels containing emulsified butterfat droplets. Journal of Food Science, 57, 892-897) and inactive fillers show little influence on gel rheology (Langley, K. R. & Green, M. L. (1989). Compression strength and fracture properties of model particulate food composites in relation to their microstructure and particle-matrix interaction. Journal of Texture Studies, 20, 191-207). SUMMARY OF THE INVENTION
Acronyms:
G' = shear storage modulus
G" = shear loss modulus
G* = complex shear modulus
γ = strain
Th = heating temperature (°C)
¾ = holding time
As used herein, the term "biopolymer" refers to a polymer that is produced by a living organism.
As used herein, the term "altered surface property" refers to at least one single-celled microorganism with at least one altered cell surface property.
As used herein, the term "treated" refers to the altering, preferably substantially inactivating, of at least one characteristic of a single-celled microorganism using means such as, but not limited to, chemical, thermal, biochemical and radiation. The treatment comprises contacting the single-celled microorganism with at least one substance that results in substantial inactivation and preferably alteration of the surface of the microorganism, and/or an alcohol, or a combination thereof. In one aspect, the at least one substance is selected from a basic compound or a salt, or the like. The basic compound is preferably an alkali metal hydroxide, most preferably sodium hydroxide, or the like. The salt is preferably a sodium or potassium salt, most preferably sodium chloride. In another aspect, the at least one substance is an enzyme preferably a protease, or the like. In another aspect, the at least one substance is an acid preferably hydrochloric acid, or the like. The alcohol is preferably selected from the group consisting of methanol, ethanol, n-propanol and isopropanol, or the like, most preferably ethanol.
As used herein, the term "substantially inactivated" refers to a single-celled microorganism that is no longer viable.
As used herein, the term "soft material" refers to a polymer, a biopolymer or a mixture of polymers or biopolymers thereof
As used herein, the term "biopolymer solution" refers to a dispersion, suspension or solution of at least one biopolymer or mixture of biopolymers.
In one aspect of the invention, there is provided a plurality of single-celled microorganisms comprising at least one substantially inactivated single-celled microorganism wherein said microorganism further comprises at least one altered surface property.
In another aspect of the invention, there is provided a process for treating at least one single- celled microorganism, preferably a plurality of single-celled microorganisms, resulting in at least one substantially inactivated single cell microorganism with at least one altered surface property, said process comprising:
a) Substantially inactivating said at least one single-celled microorganism, and b) Substantially altering said surface.
In another aspect of the invention, there is provided a use of a plurality of single-celled microorganisms comprising at least one substantially inactivated single cell microorganism with at least one altered surface property, in altering at least one property of a soft material. In one embodiment the soft material may be a biopolymer. In another embodiment, the biopolymer may be a protein or polysaccharide, such as gelatin, starch, or starch-derived material. In another aspect of the invention there is provided a soft material comprising a plurality of substantially inactivated single-celled microorganisms with at least one altered surface property. Preferably said microorganisms are present in said soft material between about 0.1% and about 30% by weight, preferably between about 0.5% and about 10% by weight and most preferably between about 1% and about 5% by weight.
In one embodiment, the single-celled microorganism is selected from the group consisting of fungi, algae and bacteria. The fungi are most preferably a yeast such as Saccharomyces cerevisiae. The algae are most preferably chlorella or spirulina. The bacteria are most preferably selected from lactic acid bacteria, preferably Lactobacillus bulgaricus and/or Streptococcus thermophilus.
In another embodiment, the at least one altered surface property of the single-celled microorganisms comprises denaturation of proteins on the cell wall, preferably selected from denaturing mannoprotein in a yeast cell wall {Saccharomyces cerevisiae) denaturing
peptidoglycan in a spirulina cell wall, denaturing glucosamine in a chlorella cell wall and denaturing peptidoglycan in a Lactobacillus bulgaricus or Streptococcus thermophilus cell wall. In another embodiment, in the process for treating a plurality of single-celled microorganisms the substantially inactivating step and the substantially altering step may occur simultaneously or sequentially, preferably simultaneously. In another embodiment, the substantially inactivating step involves the use of at least one of a substance, heat, microwave, ultraviolet light or irradiation or a combination thereof. In yet another embodiment the substantially inactivating and/or substantially altering steps are carried out by contacting the single-celled microorganism with at least one substance selected from an enzyme, a basic substance, an acidic substance or an alcohol or a combination thereof, preferably at a predetermined temperature. Preferably, the single-celled microorganisms are substantially inactivated and substantially altered by this process. In another embodiment, the treated single-celled microorganisms are subjected to a washing step.
In another aspect of the invention there is provided a process for modifying a biopolymer solution using a plurality of single-celled microorganisms comprising the steps:
1) Providing at least one biopolymer or a mixture of biopolymers;
2) Optionally providing at least one sweetener;
3) Providing a plurality of treated single-celled microorganisms comprising at
least one substantially inactivated single cell microorganism with at least one altered surface property, and
4) Contacting said at least one biopolymer with said plurality of single-celled
microorganisms and optionally with said at least one sweetener.
In another embodiment, the biopolymer is in the form of a biopolymer solution which contains about 0.1 % to about 30% by weight of biopolymer, preferably about 1 % to about 20%) by weight of biopolymer and most preferably about 3% to about 15% by weight of biopolymer. Preferably the biopolymer is a protein, polysaccharide or a combination thereof, most preferably the biopolymer is gelatin, starch or a starch-based material. In other embodiments, the sweetener is present in an amount of about 0% to about 60% by weight, preferably about 50% by weight. In one embodiment, the sweetener may be crystalline, noncrystalline or glassy in form, in another embodiment, the sweetener may be in a solid or a
liquid form. Preferably the sweetener is selected from saccharides, said saccharides are selected from monosaccharides, disaccharides or polysaccharides, derivatives and/or modified forms thereof. Preferably in another embodiment, said sweeteners are selected from combinations thereof. Most preferably the sweetener is sucrose or glucose syrup or combinations thereof.
In another embodiment, the biopolymer solution may further comprise at least one flavouring agent. In yet another embodiment, the biopolymer solution may further comprise at least one colouring agent. In another embodiment, the biopolymer solution may further comprise at least one acidulant. In another embodiment, the biopolymer solution may further comprise at least one salt. In another embodiment, the biopolymer solution may further comprise at least one antioxidant. In another embodiment, the biopolymer solution may further comprise at least one edible oil. In another embodiment, the biopolymer solution may further comprise at least one emulsifier. In another embodiment, the biopolymer solution may further comprise at least one glazing agent. In another embodiment, the biopolymer solution may further comprise at least one vitamin. In another embodiment, the biopolymer solution may further comprise at least one lipophilic agent. In another embodiment, the biopolymer solution may further comprise at least one mineral. Further and other ingredients known in the food industry to a person of ordinary skill in the art may be added to the biopolymer solution without compromising the present invention.
In another embodiment, substantially inactivating a plurality of single-celled microorganisms results in and alteration of the rheological property of the biopolymer solution. In yet another aspect, there is provided the use of said treated plurality of single-celled microorganisms of the present invention as a food-grade colloidal particle.
Other uses for said invention include but are not limited to, uses as filler particles, a texture modifier, a rheology modifier, a protein gel binder, a structure modifier, for example as precursors for developing microstructures, and as interfacial particles for encapsulation of small molecules, including but not limited to pharmaceuticals, nutraceuticals, agrochemicals, health supplements, personal health care products and cosmetics.
In a preferred embodiment of the present invention there is provided a a plurality of treated single-celled microorganisms comprising at least one substantially inactivated single-celled microorganism wherein said microorganism further comprises at least one altered surface property. The single-celled microorganisms are most preferably selected from yeast, algae and bacteria. Most preferably the algae are chlorella and spirulina, the bacteria are selected from lactic acid bacteria, for example, Lactobacillus bulgaricus or Streptococcus thermophilus, and the yeast are selected from Saccharomyces cerevisiae
Preparation of the substantially inactivated single-celled microorganism preferably involves contacting the microorganism with at least one substance resulting in substantial inactivation and preferably alteration of the surface of the single-celled microorganism, selected from a basic compound, an acidic compound, a salt, and an alcohol at a predetermined temperature. The basic substance is preferably an alkali metal hydroxide, most preferably sodium hydroxide. The acidic compound is preferably hydrochloric acid, or the like. The salt is preferably a sodium or potassium salt, most preferably sodium chloride. In one aspect, the predetermined temperature at which the inactivation process may be carried out is preferably between about 70°C and about 1 10°C, more preferably between about 80°C and 100°C and most preferably about 95 °C. The duration of the inactivation process may be about 20 minutes with optional agitation every about 5 to about 7 minutes.
Preferably, when the substance is a basic compound, an acidic compound or a salt, the substance substantially inactivates and substantially alters the surface of the single-celled microorganism. In another aspect, when the substance is an alcohol selected from the group consisting of methanol, ethanol, n-propanol and isopropanol, most preferably ethanol, the predetermined temperature at which alteration of the surface is preferably between about 15°C and about 60°C, more preferably between about 20°C and 50°C and most preferably between about 25°C and 45°C. The duration of the alteration process may be between about 12 hours and six days, most preferably between about 16 hours and five days.
In another aspect, when the substance is selected from an enzyme, the treatment comprises: 1) optionally substantially inactivating the single-celled microorganism by means discussed herein; 2) contacting the optionally substantially inactivated single-celled microorganism
with at least one enzyme for substantial alteration of the surface of the single-celled microorganism at a predetermined time and temperature from about 35°C to about 65°C resulting in substantial alteration; 3) substantially deactivating, preferably fully deactivating, the at least one enzyme, preferably at a deactivation temperature, more preferably at a deactivation temperature that is dependent on the selected enzyme.
The treated single-celled microorganisms are preferably washed, preferably with distilled water, to remove base, acid, salt, alcohol and/or enzyme from the treated single-celled microorganisms.
The biopolymer to be modified is preferably a polypeptide, a protein or polysaccharide, most preferably gelatin, starch or a starch-derived material. The formation of a solution of the biopolymer is carried out by dissolving the biopolymer in water at an elevated temperature with mixing. The preferred temperature is from about 65°C to about 100°C, preferably from about 80°C to about 100°C and most preferably about 90°C. Mixing may be accomplished by any means known to a person of ordinary skill in the art. In one embodiment, the biopolymer solution further comprises at least one sweetener, preferably a saccharide and most preferably sugar or a glucose syrup or a combination thereof. Further and other aspects of the present invention will become apparent to the person of skill in the art.
BRIEF DESCRIPTION OF THE FIGURES
Figure 1 is a confocal laser scanning microscopy (CLSM) of gel made of 6wt% gelatin and 6wt % maltodextrin subjected to Th = 40 °C, th = 30sec.
Figure 2 is a CLSM of gel made of 6wt% gelatin and 6wt% maltodextrin subjected to Th = 40 °C, th = lO min. Figure 3 is a CLSM of gel made of 6wt% gelatin and 6wt% maltodextrin containing 2wt% Lactobacillus subjected to Th = 40 °C, th = 30 sec.
Figure 4 is a CLSM of gel made of 6wt% gelatin and 6wt% maltodextrin containing 2wt% Lactobacillus subjected to Th = 40 °C, ¾ = 10 min.
Figure 5 is a CLSM of gel made of 6wt% gelatin and 6wt% maltodextrin containing 2wt% chlorella subjected to Th = 40 °C, th = 30 sec.
Figure 6 is a CLSM of gel made of 6wt% gelatin and 6wt% maltodextrin containing 2wt% chlorella subjected to Th = 40 °C, th = 10 min. Figure 7 is a CLSM of gel made of 6wt% gelatin and 6wt% maltodextrin containing 2wt% yeast subjected to Th = 40 °C, th = 30 sec.
Figure 8 is a CLSM of gel made of 6wt% gelatin and 6wt% maltodextrin containing 2wt% yeast subjected to Th = 40 °C, ¾ = 10 min.
Figure 9 is a CLSM of gel made of 6wt% gelatin and 6wt% maltodextrin containing 2wt% spirulina subjected to Th = 40 °C, th = 30 sec.
Figure 10 is a CLSM of gel made of 6wt% gelatin and 6wt% maltodextrin containing 2wt% spirulina subjected to Th = 40 °C, th = 10 min.
Figure 1 1 is a CLSM of gel made of 6wt% gelatin and 6wt% maltodextrin containing lwt% NaCl subjected to Th = 40 °C, th = 30sec. Figure 12 is a CLSM of gel made of 6wt% gelatin and 6wt% maltodextrin containing 2wt% chlorella and lwt% NaCl subjected to Th = 40 °C, th = 30 sec.
Figure 13 is a CLSM of gel made of 6wt% gelatin and 6wt% maltodextrin containing 2wt% chlorella and lwt% NaCl subjected to Th = 40 °C, th = 30 sec.
Figure 14 is a CLSM of gel made of 6wt% gelatin and 6wt% maltodextrin containing 2wt% spirulina and lwt% NaCl subjected to Th = 40 °C, th = 30 sec.
Figure 15 is a CLSM of gel made of 6wt% gelatin and 6wt% maltodextrin containing 2wt% spirulina and lwt% NaCl subjected to Th = 40 °C, ¾ = 30 sec.
Figure 16 is a time-dependent change in storage modulus (G^of gel made with 6wt% gelatin and 6wt% maltodextrin subjected to Th = 40 °C and ¾ = 30 sec: without added cell■; with 2 wt% Lactobacillus ·; with 2wt% chlorella,♦; with 2wt% yeast, A; with 2wt% spirulina, *. Loss modulus (G") is adjacent to X axis
Figure 17 is a time-dependent change in G' of gel made with 6wt% gelatin and 6wt% maltodextrin subjected to Th = 40 °C and th = 10 min: without added cell■; with 2 wt% Lactobacillus ·; with 2wt% chlorella,♦; with 2wt% yeast, A; with 2wt% spirulina, *. G" is adjacent to X axis
Figure 18 is a time-dependent change in G' of gel made with 6wt% gelatin and 6wt% maltodextrin subjected to Th = 40 °C and ¾ = 30 sec: without salt, T; with lwt% salt, *; with lwt% salt and 2wt% spirulina# ; with lwt% salt and 2wt% chlorella,♦.
Figure 19 is a strain-dependence complex modulus (G*) of gel made with 6wt% gelatin and 6wt% maltodextrin subjected to T = 40 °C and ¾ = 30 sec after 1 hour ageing at 25 °C: without added cell,□; with 2wt% Lactobacillus, O; with 2wt% chlorella, ; with 2wt% yeast, Δ; with 2wt% spirulina,
Figure 20 is a G' of gel made with 6wt% gelatin and 6wt% maltodextrin subjected to Th = 40 °C for th = 30 sec (T) and Th = 40 °C for th = 10 min (□) after 1 hour ageing at 25 °C: without added cell (control); 6wt% gelatin and 6wt% maltodextrin with 2wt% Lactobacillus (cont+lact); 6wt% gelatin and 6wt% maltodextrin and 2wt% chlorella (cont+chlo); 6wt% gelatin and 6wt% maltodextrin and 2wt% yeast (cont+yeas); 6wt% gelatin and 6wt% maltodextrin and 2wt% spirulina (cont+spir). Figure 21 is a I % | loss of G' for 1 -hour aged gels at 25 °C, 100 x[G' of (Th = 40 °C for th = 10 min) - G' of (Th = 40 °C for th = 30 sec)]/G' of (Th = 40 °C for th = 30 sec), 6wt% gelatin and 6wt% maltodextrin without added cell (control); 6wt% gelatin and 6wt% maltodextrin with 2 wt% Lactobacillus (cont+lact); 6wt% gelatin and 6wt% maltodextrin and 2wt%
chlorella (cont+chlo); 6wt% gelatin and 6wt% maltodextrin and 2wt% yeast (cont+yeas); 6wt% gelatin and 6wt% maltodextrin and 2wt% spirulina (cont+spir).
Figure 22 is a CLSM of a sample made of 3wt% gelatin and 10wt% maltodextrin containing 0.1 wt% spirulina and lwt% substantially inactivated yeast (by 1 M solution of NaOH) subjected to Th = 40 °C, th = 30 sec.
Figure 23 is a CLSM (higher magnification) of a sample made of 3wt% gelatin and 10wt% maltodextrin containing 0.1 wt% spirulina and lwt% substantially inactivated yeast (by 1 M solution of NaOH) subjected to Th = 40 °C, th = 30 sec.
Figure 24 is a CLSM of sample made of 3wt% gelatin and 10wt% maltodextrin containing 1 wt% olive oil and lwt% substantially inactivated yeast (by 1 M solution of NaOH) subjected to Th = 40 °C, th = 30 sec.
Figure 25 is a CLSM (higher magnification) of sample made of 3wt% gelatin and 10wt% maltodextrin containing 1 wt% olive oil and lwt% substantially inactivated yeast (by 1 M solution of NaOH) subjected to Th = 40 °C, th = 30 sec. Figure 26 is a time-dependent change in G' of gel made with 6wt% gelatin-only gels subjected to Th = 40 °C and th = 30 sec: without added cell■; with 2wt% chlorella,♦; with 2 wt% Lactobacillus ·; with 2wt% yeast (treated with NaOH), A; with 2wt% spirulina, *. G" is adjacent to X axis. Figure 27 is a time-dependent change in G' of gel made with 5wt% gelatin and 3 wt% inulin gels subjected to Th = 40 °C and th = 30 sec: without added cell■; with 2 wt% Streptococcus thermophilus ·. G" is adjacent to X axis.
Figure 28 is a time-dependent change in G' of gel made with 6wt% gelatin and 6 wt% starch and 20wt% sugar and 30 wt% glucose syrup subjected to Th = 40 °C and th = 30 sec: without added cell ■; with 2 wt% yeast substantially inactivated/modified with enzymatically treatment ·. G" is adjacent to X axis.
DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
With reference to Figure 1, confocal laser scanning microscopy (CLSM) shows a gelatin- maltodextrin biopolymer sample (without cells) subjected to Th = 40 °C for ¾ = 30 sec. Its microstructure resembles a typical water-in-water emulsion, where the gelatin-rich phase 10 forms a continuous phase containing the droplet-like maltodextrin-rich phase 12. The configuration of the microstructure clearly indicates that nucleation and growth served as the phase separation pathway.
With reference to Figure 2, CLSM shows a gelatin-maltodextrin biopolymer sample (without cells) held at a longer holding time of th = 10 min at Th = 40 °C. This holding time intensified the extent of phase separation and coarsened the sample microstructure. Maltodextrin-rich droplets 20 merged to form larger droplets in the microstructure. Secondary phase separation also occurred in the system, with gelatin droplets appearing inside the larger maltodextrin- rich droplets.
With reference to Figure 3, CLSM shows a gelatin-maltodextrin biopolymer with substantially deactivated Lactobacillus (2wt%) subjected to T = 40 °C for th = 30 sec. Cells 30 reside on the interface and associate with the gelatin phase 32, and the gelatin forms continuous structures seemingly out of equilibrium.
With reference to Figure 4, CLSM shows a gelatin-maltodextrin biopolymer with substantially deactivated Lactobacillus (2wt%) held for a longer holding time of ¾ = 10 min at Th = 40 °C. The phase separation proceeds further when the sample is kept at 40 °C for 10 minutes, with the microstructure reaching an apparent degree of equilibrium. The coarsened, cell-coated gelatin droplets 40 in the sample merged into a continuous gelatin phase, and some of them formed larger droplets with extended features. Maltodextrin-rich regions 42 appeared as void regions depleted of gelatin and cells. Gelatin-rich domains manifested a high accumulation of cells in the form of clusters, but some dark (maltodextrin-rich) patches also existed in cell clusters within these gelatin-rich domains.
With reference to Figure 5, CLSM shows a gelatin-maltodextrin biopolymer with substantially inactivated chlorella (2wt%) subjected to Th = 40 °C for th = 30 sec. In this sample, cells were associated with the gelatin phase 50 and built up a continuous phase.
Maltodextrin forms included phases in the shape of individual droplets 52 (dark circles). This microstructure indicates that phase separation proceeded through nucleation and growth. Interestingly, cells were not associated with the interface, and maltodextrin regions at the interface resemble void regions with blunt edges.
With reference to Figure 6, CLSM shows a gelatin-maltodextrin biopolymer with substantially inactivated chlorella held at a longer holding time of th = 10 min at Th = 40 °C. Over this holding time, the sample coarsened and phase separation proceeded further. Scattered maltodextrin-rich regions 60, in the form of crescents and incomplete circles, appeared in the microstructure. These features partially resembled open-cell foam, spongelike microstructures, exhibiting inter-connected gelatin-rich stretched domains 62 filled with small maltodextrin-rich (excluded phase) droplets. These stretched domains intersect in the nodes of the built scaffolding, which holds the larger blobs of maltodextrin-rich phase inside the cells.
With reference to Figure 7, CLSM shows a gelatin-maltodextrin biopolymer with substantially inactivated yeast (2wt%) subjected to Th = 40 °C for th = 30 sec. The microstructure displays bicontinuous features, with cells associated mostly with the gelatin phase 70. The lack of any round droplets in the microstructure suggests that the pathway of phase separation was spinodal decomposition without secondary phase separation. However, the presence of cells in the system profoundly affects the microstructure: the interface boundaries are not smooth and do not possess a curvature similar to conventional spinodal- type microstructures. On the contrary, the interface boundaries are rather linear and jagged. The alignment of the cells on the interface influenced this interface morphology.
With reference to Figure 8, CLSM shows a gelatin-maltodextrin biopolymer with substantially inactivated yeast (2wt%) held at a longer holding time of th = 10 min at Th = 40 °C. Here, the domains exhibit more expansion due to additional coarsening caused by this longer thermal treatment. The bicontinuous structure and interfacial features of the phase boundaries of the microstructure were preserved; i.e., they remained more or less linear and jagged. The domains 80 had irregular spacing distances, and some edges of the gelatin-rich domains 82 appeared narrow and starched. These are the regions where gelatin defused inside the domains, and cells on the interface formed ductile-type features.
With reference to Figure 9, CLSM shows a gelatin-maltodextrin biopolymer with substantially inactivated spirulina (2wt%) subjected to Th = 40 °C for ¾ = 30 sec. The microstructure of gelatin-maltodextrin gels containing spirulina 90 is fairly similar to that of gelatin-maltodextrin gels containing chlorella. However, the number and size of maltodextrin-rich domains 92 in the sample containing spirulina appeared lower than those of the sample containing chlorella.
With reference to Figure 10, CLSM shows a gelatin-maltodextrin biopolymer with substantially inactivated spirulina held at a longer holding time of ¾ = 10 min at Th = 40 °C. The microstructure of gelatin-maltodextrin gels containing spirulina held for this length of time resembled their counterpart sample containing chlorella, except that the size and number of maltodextrin-rich domains - in the form of partial crescents and incomplete circles - were smaller than those in the sample containing chlorella. However, the size and number of maltodextrin-rich droplet-like features 100 (included phase) within the gelatin-rich domains 102 appear higher than those in the sample containing chlorella.
With reference to Figure 1 1, CLSM shows a gelatin-maltodextrin biopolymer sample (without cells) containing lwt% NaCl that was subjected to Th = 40 °C for th = 30 sec. The addition of lwt% salt to gelatin-maltodextrin gels under this thermal treatment significantly enhanced the extent of phase separation. The sample microstructure was much more coarsened than that of samples without salt subjected to similar thermal treatment (Figure 1 above), including that of the sample with a longer holding time of ¾ = 10 min (Figure 2 above). Some maltodextrin-rich droplets 1 10 appeared larger than those in samples without salt (Figures land 2 above), and the presence of larger gelatin droplets within the maltodextrin-rich droplets 1 10 indicated that secondary phase separation had also progressed further.
With reference to Figures 12 and 13 (higher magnification), CLSM shows a gelatin- maltodextrin biopolymer with substantially inactivated chlorella (2wt%) with lwt% NaCl subjected to Th = 40 °C for th = 30 sec. The addition of salt to the gelatin-maltodextrin gel containing chlorella caused drastic changes in the system microstructure, such as phase inversion and the adsorption of cells on the gelatin-maltodextrin interface. In the system
containing salt, cells associated with the gelatin phase 120 were similar to those in the system without salt. However, with the addition of salt to the system, the continuous gelatin phase transformed into a discontinuous phase, forming individual gelatin droplets 120 scattered in a maltodextrin continuous phase 122. A very distinctive feature of the microstructure is the association of the cells with interfacial regions. As we can clearly see, cells 130, 132 are adsorbed at the interface. The microstructure well-represents a water-in-water emulsion, consisting of a continuous maltodextrin-rich phase 134 and flocculated droplets of a gelatin- rich phase 136. With reference to Figure 14 and 15 (higher magnification), CLSM shows a gelatin- maltodextrin biopolymer with substantially inactivated spirulina (2wt%) with lwt% NaCl subjected to Th = 40 °C for ¾ = 30 sec. The addition of salt to a gelatin-maltodextrin gel containing spirulina caused immense changes in system microstructure. The phase separation pathway form nucleation and growth changed to spinodal decomposition, and consequently the microstructure transformed from droplets and a continuous matrix to a semi-bicontinuous microstructure. Predominantly, the gelatin-rich phase 140 constructs the continuous phase, and the maltodextrin-rich phase 142 forms non-spherical blobs as an included phase. In contrast to the sample without salt (Figure 9), cells normally associated with the gelatin-rich phase were adsorbed at the gelatin-maltodextrin interface 144.
The modified biopolymers of the present invention can be subjected to rheological measurements, preferably small-deformation oscillatory measurements to demonstrate the improved characteristics of the biopolymers modified by the plurality of inactivated single- celled microorganism. Measurement of storage modulus (G') and loss modulus (G") of phase-separated biopolymer gels may be carried out at about 25°C.
With reference to Figure 16, time-dependent G' and G" of phase-separated gels at 25 °C, illustrating samples containing single cell microorganisms as well as a control sample without added cells. Prior to taking measurements, all samples were quenched from « 90 °C to 40 °C and subjected to Th = 40 °C for th = 30 sec before being quenched to 25 °C. After 1 min equilibrium at 25 °C, the measurements commenced and continued for 1 hour. The gelatin plus maltodextrin system showed the lowest G' after 1 hour (926 ± 13.4 Pa). In contrast, systems containing added single cells (2wt%) showed higher G' than that of the sample
without added cells. With Lactobacillus, G' increased 4.7 % to 970 ± 26 Pa. With chlorella, G' was raised by 54.4 % to 1430 ± 17.32 Pa. The addition of yeast caused a 97.2% increase in G' to 1826.6 ± 35.1 Pa. Finally, the incorporation of spirulina caused a pronounced 131.4 % increase in G', to 2143.3 ± 37.8 Pa. In the second set of experiments, we changed the holding time at 40 °C from 30 sec to 10 min (Th = 40 °C for th = 10 min), followed by a similar set of rheological measurements.
With reference to Figure 17, time-dependent G' and G" of phase-separated gels at 25 °C, consisting of samples containing single cell microorganisms and one control sample without added cells (each held at 40 °C for 10 min). As in the previous experiments, all samples containing single cell organisms (2wt%) showed higher G' than that of samples without added cells. Of the gels with added cells, the gelatin plus maltodextrin system showed the lowest G' after 1 hour (648.6 ± 12 A Pa). With Lactobacillus, G' increased 42.34 ± 0.1 % to 923.3 ± 30 Pa. With chlorella, G' increased 104% to 1323 ± 40.41 Pa. The addition of yeast caused a 155.3%) increase in G' to 1656.6 ± 41.6 Pa, and the incorporation of spirulina caused a 215 % increase in G' to 2043.3 ± 70.9 Pa.
With reference to Figure 18, time-dependent G' and G" of phase-separated gels at 25 °C, illustrating three samples - one containing 2wt% chlorella, one with 2wt% spirulina, and a control sample without added cells - in the presence of lwt% salt (NaCl). As in the first set of experiments (Figure 16), prior to taking measurements all samples were quenched from « 90 °C to 40 °C and held at this temperature for 30 sec (Th = 40 °C for th = 30 sec), then cooled down to 25 °C. After 1 min equilibrium, the measurements commenced and continued for 1 hour. The addition of as little as lwt% of salt to the gelatin plus maltodextrin system caused a significant reduction of G' in comparison to the system without salt: a 38% loss, reducing the G' from 926 ± 13.4 Pa to 574 ± 12.12 Pa. In this salt-containing system, the addition of 2wt% spirulina improved the G' by 17.4%, to 674 ± 20 Pa. Similarly, the addition of 2wt% chlorella increased the G' by 79.44%, raising the initial value (926 ± 13.4 Pa) to 1030 ± 10 Pa. With reference to Figure 20, nonspecific interactions of single cells with the gel matrix and the nature of each group of added cells were observed by the different rheological responses with time/temperature treatments (Th = 40 °C and ¾ = 30 sec and 10 min).
With reference to Figures 22 and 23 (higher magnification) CLSM micrographs show phase- separated samples encapsulating 0.1 wt% spirulina 150, 152 within a discontinuous 3 wt% gelatin phase 154 scattered in a 10 wt% maltodextrin continuous phase 156. Gelatin domains are encapsulated with substantially inactivated 1 wt% yeast (by 1 M solution of NaOH).
With reference to Figures 24 and 25 (higher magnification) CLSM micrographs show phase- separated samples encapsulating 1 wt% olive oil 160, 162 within discontinuous 3 wt% gelatin phase 164 scattered in a 10 wt%. maltodextrin continuous phase 166. Gelatin domains are encapsulated with substantially inactivated 1 wt% yeast 168, 169 (by 1 M solution of NaOH).
These micrographs demonstrate partitioning of the particles (spirulina) and oil droplets in the dispersed gelatin phase due to liquid-liquid phase separation. Since this encapsulation method does not require organic solvents or other chemicals, sensitive substances like cells and vulnerable lipophilic agents can be preserved within the phase-separated domains with the extra protection of the absorbed particles (yeast cells) at the liquid-liquid interface.
With reference to Figure 26, time-dependent G' and G" of gelatin-only gels, (single phase, containing one biopolymer) at 25 °C, illustrate samples containing single cell microorganisms as well as a control sample without added cells. Prior to taking measurements, all samples were quenched from « 90 °C to 40 °C and subjected to Th = 40 °C for th = 30 sec before being quenched to 25 °C. After 1 min equilibrium at 25 °C, the measurements commenced and continued for 1 hour. The gelatin without added cells system showed the lowest G' after 1 hour (447 ± 8 Pa). In contrast, systems containing added single cells (2wt%) showed higher G' than that of the sample without added cells. With chlorella, G' increased 58.2 % to 707.3 ± 20 Pa. With Lactobacillus, G' was raised by 64.7 % to 736.3 ± 22.8 Pa. The addition of yeast caused a 1 1 1.5% increase in G' to 945.6± 17 Pa. Finally, the incorporation of spirulina caused a pronounced 155.7 % increase in G', to 1 143.3 ± 55 Pa.
With reference to Figure 27, time-dependent G' and G" of gelatin-inulin gels (single phase, containing two biopolymers) at 25 °C, illustrate samples containing single cell microorganisms as well as a control sample without added cells. Prior to taking measurements, all samples were quenched from « 90 °C to 40 °C and subjected to Th = 40 °C for ¾ = 30 sec before being quenched to 25 °C. After 1 min equilibrium at 25 °C, the
measurements commenced and continued for 1 hour. The G' of gelatin-inulin sample without added cells reached to 261.3 ± 1 1.54 Pa after 1 hour. In contrast, systems containing added single cells (2wt%) showed higher G' than that of the sample without added cells. With Streptococcus thermophilus, G' increased 69.5 % to 443 ± 7 Pa.
With reference to Figure 28, time-dependent G' and G" of gelatin 6 wt% and starch 6 wt% and sugar 20 wt% and glucose syrup 30 wt% gels at 25 °C, illustrate samples containing single cell microorganisms as well as a control sample without added cells. Prior to taking measurements, all samples were quenched from « 90 °C to 40 °C and subjected to Th = 40 °C for th = 30 sec before being quenched to 25 °C. After 1 min equilibrium at 25 °C, the measurements commenced and continued for 1 hour. The G' of gelatin/starch/sugar/glucose syrup sample without added cells reached to 3573.3 ± 87.3 Pa after 1 hour. In contrast, systems containing 2 wt% single cells (substantially inactivated/modified yeasts with enzymatic treatment) showed higher G than that of the sample without added cells. With added 2 wt% enzymatically treated yeast, G' increased 30.5 % to 4666.6 ± 104. Pa.
Strain-sweep tests at a constant frequency may be carried out on the modified biopolymer solutions to assess viscoelastic properties of the modified biopolymer. With reference Figure 19, strain sweep tests at constant frequency (1 Hz) and temperature (25 °C) on samples after the completion of small oscillatory deformation measurements (samples subjected to Th = 40 °C for ¾ = 30 sec). In this test, the changes in complex shear modulus (G*) as a function of shear strain amplitude in the oscillatory mode were monitored. At the lower limit of strain γ, 0.01 (1%), the initial G*of each sample matched its G' valve. Results showed that all samples had a long linear viscoelastic region. Samples containing 2wt% Lactobacillus showed strain- softening behaviour (decreasing the G* under strain); samples containing 2wt% spirulina and 2wt% yeast displayed similar behaviour, but to a lower extent with spirulina and even more moderately in the sample containing yeast. For all samples, increasing the strain to approximately 1-2.5 (100-250%) fractured the sample on the macroscopic scale, causing a more than 5% decrease in the initial value of G*. Before reaching the fracture point, all samples showed strain hardening behaviour, becoming resistant to flow under greater deformation.
Without being bound by theory phase separation dictates the microstructure morphologies in a thermodynamic-incompatible biopolymer solution. A phase-separated sample with no added treated single-celled microorganisms, such yeast, chlorella, spirulina or Lactobacillus, represented a typical water-in-water emulsion, with spherical domains of one phase being surrounded by the other continuous phase in the matrix. CLSM observations revealed that the microstructure of gelatin-maltodextrin gel was altered in the presence of a plurality of treated single-celled microorganisms. All added cells resided in the gelatin-rich phase - presumably, the adsorption of protein at the particle surface lowered the interfacial energy contact of the inactivated single-celled microorganisms, which in turn favoured the particles residing in the protein-rich phase.
In one embodiment of the present invention, improvement of the rheological properties of the binary (gelatin-maltodextrin) gels was achieved, but also to minimize the adverse effect of phase separation on G'. With reference to Figure 21 , the | % I difference of G' for 1-hour aged gels at 25 °C (subjected to Th = 40 °C, th = 30 sec and Th = 40 °C, th = 10 min). Phase separation reduced the G' substantially: 29.94% from its original value in the gel sample without adding treated single-celled microorganisms. This G' loss significantly improved to 9.3% with the addition of 2wt% yeast and further to 7.4% with the addition of 2wt% chlorella. The G' loss reached a minimum of 4.8% with 2wt% Lactobacillus and 4.6% with 2 wt% spirulina. These results clearly indicate that the incorporation of a plurality of treated single-celled microorganisms into a phase-separated gelatin-maltodextrin gel could stabilize the rheological property of the gels against the adverse effect of phase separation.
The presence of a plurality of treated single-celled microorganisms in the gelatin- maltodextrin gel had a pronounced effect on the fracture behavior of gels under increased strain. In general, large deformation of gels is related to fracture failure and rupture propagation in the gel matrix. In microscopic level cracks, the initiation and its formation determine the macroscopic fractures. Gelatin-maltodextrin gel is considered a filled gel and, depending on the continuous and included phase, it could be classified as a gelatin gel filled with a maltodextrin included phase or vice versa.
The addition of a plurality of treated single-celled microorganisms to a phase-separated gelatin-maltodextrin gel significantly alters the developing microstructures under phase
separation conditions. By using the single-celled microorganisms as colloidal particles, it is possible to create a group of microstructures that never existed before. The presence of a plurality of treated single-celled microorganism enhances the rheological properties of the phase-separated gel. It can also enhance the G' of the gel and, more importantly, it reduces the negative impact of phase separation on G'. Most likely, as the biopolymer-cell forms stiffer chains, the resulting gel becomes more resistance to rheological changes induced by phase separation. Treated single-celled microorganisms can be used as colloidal particles in thermodynamic-incompatible biopolymer solutions, or thermodynamic-compatible biopolymer solutions or in biopolymer solutions as filler particles. Different groups of treated single-celled microorganisms create different types of microstructures and impart different rheological properties to the mixture. These treated cell-incorporated biopolymers emulsions ("cibe") could be considered as an addition to food gels, providing diverse microstructures and enhanced rheological properties. Non-limiting examples are provided as follows.
Examples
Material
Food-grade gelatin from acid-treated porcine skin (Type A, pi 7.0 - 9.0, Bloom 300 ± 25, moisture content < 12.0 wt %, ash content < 1.0 wt %) was supplied by Sigma-Aldrich (Oakville, ON, Canada). Eliane™ MD 2, maltodextrin obtained by enzymatic conversion of potato starch moisture content <8 wt %, ash content < 1 wt %) was kindly supplied by National Starch (Bridgewater, NJ, USA). Yeast (product #51475) (Sacchromyces cerevisiae) was supplied by Sigma-Aldrich (Oakville, ON, Canada). Spirulina and Chlorella were supplied by PureBulk Inc. (Roseburg, OR, USA). Lactobacillus bulgaricus, LB-12, in a form of frozen pellet (DVS) was kindly offered by Chr. Hansen (Milwaukee, WI, USA). FITC (fluorescein-5-isothiocyanate, 90% HLPC grade) was provided by Sigma-Aldrich (Oakville, ON, Canada). Anhydrous ethyl alcohol was supplied by Commercial Alcohols Inc. (Brampton, ON, Canada). Sodium hydroxide (NaOH) and salt (NaCl) was supplied by Fisher Scientific (Ottawa, ON, Canada). Distilled water was used throughout. Streptococcus thermophilus, ST-M5 in the form of freeze-dried pellets were supplied from Chr. Hansen (Milwaukee, WI, USA). Protease enzyme, Protin NY 100, was kindly supplied by Amano Enzyme INC (Nagoya, Japan). Hydrochloric acid A.C.S. 36.5-38% was supplied by Fisher
Scientific (Ottawa, ON, Canada). Sucrose (sugar) was provided by Sigma-Aldrich (Oakville, ON, Canada). Perfectamyl™ Gel-EMP, Oxidised potato starch obtained by oxidation of native potato starch with sodium hypochlorite moisture content <12 wt %, ash content < 2 wt %) was kindly supplied by National Starch (Bridgewater, NJ, USA). Inulin, Fiberrific™ was supplied by Pure-le Natural (Barrie, ON, Canada). Glucose syrup, DE 40-46 and olive oil were purchased from local supermarket.
Example 1 - Cell preparations
Single-celled microorganisms were treated with NaOH, HC1, saturated salt solution, enzyme or alcohol solutions. After treatment the single-celled microorganisms were washed repeatedly with distilled water until soluble substances substantially extracted from the cells and centrifugation of cell/distilled water dispersion resulted in a substantially clear and transparent supernatant (water) and homogenous and uniform sediment (cells). After washing pH was adjusted to 7 ±0.2 for cells treated with NaOH or HC1. Moisture (water content) of all prepared cells was adjusted to 89-95 wt% by measuring the solid contents of the dispersion of each prepared cell by means of water evaporations at 50 °C using a thermostat controlled oven. The electric charge of the cells and zeta potential (ζ) were measured with a 90 Plus™ particle size analyzer provided by Brookhaven Instruments Corporation (Holtsville, USA). Example 2 - Yeast preparation
Yeast cells were suspended in a 1 M solution of NaOH at a concentration of 10 wt% in a sealed screw cap glass bottle. The yeast-containing bottle was placed in water bath at 95 °C for 20 min and it was shaken regularly every 5-6 min for 15-20 sec. Then, the glass bottle was removed from the water bath and left at room temperature to sediment the undissolved fraction of yeast cells from the solution. The supernatant was discarded and each 15 ml of sediment was transferred to a 50 ml centrifuge tube and washed 7-9 times with 30 ml of water by repeated re-suspension/centrifugation cycles (5 min, 3000 rpm). After each stage of centrifugation, the slimy portion at the top of the sediment and the solid grain-like material at the bottom of the sediment in the centrifuge tubes were discarded. At the final stage of centrifugation, a clear transparent supernatant (water) and a homogeneous and uniform sediment were obtained. The pH of the final solution was adjusted to 7 ± 0.2, zeta potential ζ = -16 ± 1.06 mV
Example 3 - Spirulina preparation
Spirulina cells were prepared similarly to the yeast cells, but after thermal treatment, the whole suspension was transferred to a centrifuge tube and longer cycles (15 min, 3000 rpm) were applied (zeta potential ζ = -14 ± 1.88 mV).
Example 4 - Chlorella preparation
Chlorella cells were suspended in a saturated salt solution with a concentration of 10 wt% in a sealed screw cap glass bottle. The Chlorella-containing bottle was placed in a water bath at 95 °C for 20 min and it was shaken regularly every 5-6 min for 15-20 sec. Then, the glass bottle was removed from the water bath and left at room temperature to sediment the chlorella cells from the solution. The supernatant was discarded and the sediment was mixed with an equal volume of 50% (v/v) ethanol solution. The mixture was kept in a sealed glass bottle for 5 days at 45 °C in a thermostat-controlled oven. During the inculcation, the alcohol fraction of the mixture phase-separated from the solution, 3 times the alcohol-rich supernatant was replaced with fresh ethanol, and the sample-containing bottle was shaken manually. After incubation, the alcohol fraction of the mixture was discarded, and each 15 ml of sediment was transferred to a 50 ml centrifuge tube and washed 5 times with 30 ml of water by repeated re-suspension/centrifugation cycles (5 min, 3000 rpm) until a clear transparent supernatant was obtained at the last stage of centrifugation (zeta potential ζ = - 55.79 ± 1.08 mV).
Example 5 - Lactobacillus bulgaricus preparation
Lactobacillus cells in the form of frozen pallets were thawed and transferred to a 50 ml centrifuge tube and kept in a water bath at 95 °C for 20 min followed by centrifugation for 15 min at 3000 rpm. Then, supernatant and solid sediments were separated from cell dispersions. Each 15-20 ml of cell dispersion was transferred to a 50 ml centrifuge tube and washed 4-5 times with 30 ml water by repeated re-suspension/centrifugation cycles (15 min, 3000 rpm). After each stage of centrifugation, the solid, cake-like sediment at the bottom of the sediment in the centrifuge tubes was discarded. Next, the cell suspensions were mixed with an equal volume of 50% (v/v) ethanol solution in a sealed glass bottle using a magnetic stirrer overnight (16 hours) at room temperature. Then, once again, cell dispersions were transferred to a 50 ml centrifuge tube and were washed 5-7 times with 30 ml of water by repeated re- suspension/centrifugation cycles (15 min, 3000 rpm). After each stage of centrifugation, the
solid cake-like sediment at the bottom was discarded until a clear transparent supernatant and a monotonous sediment were obtained (zeta potential ζ = +5.96 ± 3.07 mV).
Example 6 - Preparation of solutions
The gelatin and maltodextrin solutions were prepared in separate, sealed, screw-cap glass vials (20 ml) by placing them in a 90 °C water bath for 10 min for maltodextrin and for 3 min for the gelatin solution, with vortexing at 10-15 sec intervals at 3000 rpm (Fisher Scientific, Nepean, ON, Canada). The cell suspension was added to the gelatin-containing vial and vortexed as above. For the final sample preparation, solutions of twice the required final biopolymer concentrations were prepared and mixed with equal weights of the biopolymer solutions. The final blends were mixed at « 90 °C and again placed in a water bath at « 90 °C for 1-2 min with repeated vortexing. This was followed by ultrasonication for « 10 s at « 90 °C to remove any air bubbles (Eumax® UD50SH-2L ultrasonic bath, Kwun Wah Int. Ltd, Hong Kong). For the confocal laser scanning microscopy of the control sample (without cell), the gelatin solution also contained ~ 0.001 wt % FITC.
Example 7 - Thermal treatment and small-deformation rheometry
A Physica MCR 301 rheometer (Anton Paar GmbH, Graz, Austria), equipped with a Peltier plate temperature control unit (P-PTD 200), was used to perform small-deformation oscillatory rheometery. All measurements were carried out with parallel plate geometry (PP 25/TG) with a diameter of 25mm. The time-dependent storage (G') and loss moduli (G") were measured at 25 °C at a constant frequency of 1 Hz and a target strain of 0.2% for up to 70 min. To avoid sample drying, the measuring geometry was covered with a solvent trap containing a moist strip of tissue paper.
Preceding each measurement, the temperature of the Peltier plate was set at 40 °C and the mixed hot biopolymer solution (at 90 °C) was poured directly onto the hot plate. The geometry was then lowered onto the sample to an operating gap width (1 mm) and the sample was carefully trimmed and held at 40 °C temperature of holding (Th) for 2 different holding times (¾) of 30 seconds and 10 minutes to initiate and increase the extent of phase separation. After thermal treatments at 40 °C, the temperature of the rheometer cell was decreased from 40 °C to 25 °C at 16 °C min"1, and the sample was kept for 1 minute at 25 °C to ensure the equilibrium. At this point, measurements were commenced and lasted for 1 hr. Using this standard thermal treatment (i.e., Th = 40 °C for th = 30 sec), a group of phase-separated
samples with a relatively low extent of phase separation were produced. And with another thermal treatment (Th = 40 °C for th = 10 min), another group of samples with a higher extent of phase separation was produced. All results herein reported are based on more than triplicate runs.
Example 8 - Confocal laser scanning microscopy (CLSM)
Confocal microscopy was performed using an upright Zeiss LSM 510 (Carl Zeiss, Toronto, ON, Canada). The CLSM was operated in fluorescent mode with an Ar laser source (488 nm). The emission spectra were collected with 1 channel set at 505 nm. No fluorescent labeling was used for cell-containing samples, since autofluorescence properties of the cell were sufficient for CLSM observations. To subject the CLSM samples to a thermal treatment similar to the rheology experiments, a flat metal washer with 2 cover slips was used as a sample holder, and the sample was sandwiched within the metallic washer between the 2 cover slips. This holder was placed on the Peltier plate temperature control unit of the rheometer, equilibrated, and then samples were processed as per the thermal conditioning used for the rheological measurements. After a 10 min hold at 25 °C, the sample holder was transferred to the CLSM stage for characterization. 10 χ and 20 χ objective lenses were used. Images were recorded at 25 °C at a resolution of 1024 χ 1024 pixels. Image optimization was performed using the LSM 510's built-in image analysis software. Images shown herein are representative of the microstructure seen for a given composition.
Example 9 - Streptococcus thermophilus preparation
Streptococcus thermophilus cells in the form of freeze-dried pallets were soaked and dispersed by distilled water and transferred to a 50 ml centrifuge tube. Centrifugation for 15 min at 3000 rpm and re-suspension were repeated 4-5 times until the cake-like sediments (remnants of the cell culture) were separated from the cells. Next, hydrochloric acid (32-38% solution) was added to the cell suspensions (around 50 wt% cells) to obtain 1 M acid cell dispersion. The acid-cell solution was transferred to a sealed screw cap glass bottle and placed in a water bath at 95 °C for 20 min and it was shaken regularly every 5-6 min for 15- 20 sec.
Then the cell suspension was transferred to a 50 ml centrifuge tube and washed 6-7 times with water by repeated re-suspension/centrifugation cycles (15 min, 3000 rpm). After each stage of centrifugation, any remaining cake-like materials at the bottom of the sediment in the
centrifuge tubes were discarded. At the final stage of centrifugation, a clear transparent supernatant (water) and homogeneous and uniform sediment (cell) were obtained. The pH of the final solution was adjusted to 7 ± 0.2, zeta potential ζ = -5.39 ± 0.17 mV Example 10 - Yeast preparation with enzymatic treatment
Yeast cells were suspended in a 2 wt% enzyme (Protin NY 100) solution with a concentration of 10 wt% in a sealed screw cap glass bottle. The yeast-containing bottle was placed in a thermostat-controlled oven at 45 °C for 24 hours. Then, the glass bottle was removed from the thermostat-controlled oven and it was placed in a water bath at 95 °C for 50 minutes. Then, the glass bottle was removed from the water bath and left at room temperature to sediment the yeast cells from the solution, the supernatant was discarded and each 15 ml of sediment was transferred to a 50 ml centrifuge tube and washed 7-8 times with 30 ml of water by repeated re-suspension/centrifugation cycles (5 min, 3000 rpm). After each stage of centrifugation, the slimy portion at the top of the sediment and the solid grain-like material at the bottom of the sediment in the centrifuge tubes were discarded until a clear transparent supernatant was obtained at the last stage of centrifugation (zeta potential ζ = - 14.37± 0.14 mV).
Although the above examples are on a laboratory scale, a person of ordinary skill in the art reading the above examples will be able to carry out the present invention on an industrial scale.
As many changes can be made to the preferred embodiment of the invention without departing from the scope thereof, it is intended that all matter contained herein be considered illustrative of the invention and not in a limiting sense.
Claims
I . A plurality of single-celled microorganisms comprising at least one substantially inactivated single-celled microorganism wherein said at least one substantially inactivated single-celled microorganism further comprises at least one altered surface property.
2. The microorganisms of claim 1 wherein the single-celled microorganisms are selected from the group consisting of fungi, algae and bacteria.
3. The microorganisms of claim 1 wherein the at least one altered surface property comprises a denatured surface protein.
4. The microorganisms of claim 2 wherein the bacteria is selected from lactic acid bacteria.
5. The microorganism of claim 4 wherein the lactic acid bacteria are selected from Lactobacillus bulgaricus or Streptococcus thermophilus.
6. The microorganisms of claim 2 wherein the fungi is selected from a yeast.
7. The microorganism of claim 6 wherein the yeast is Saccharomyces cerevisiae.
8. The microorganisms of claim 2 wherein the algae is selected from a single-celled group.
9. The microorganism of claim 8 wherein the single-celled group is selected from chlorella or spirulina.
10. A process for treating at least one single-celled microorganism, preferably a plurality of single-celled microorganisms, resulting in at least one substantially inactivated single cell microorganism with at least one altered surface property, said process comprising: a) Substantially inactivating said at least one single-celled microorganism, and b) Substantially altering said surface.
I I . The process of claim 10 wherein step a) comprises inactivating said at least one single-celled microorganism with at least one of a substance, heat, microwave, ultraviolet or irradiation
12. The process of claim 10 wherein step b) comprises treating said at least one single- celled microorganism with at least one of an enzyme, a basic substance, an acidic substance, a salt or an alcohol and combinations thereof.
13. The process of claim 12 wherein the basic substance is sodium hydroxide.
14. The process of claim 12 wherein the alcohol is selected from the group consisting of methanol, ethanol, n-propanol and isopropanol and combinations thereof.
15. The process of claim 12 wherein the acid is hydrochloric acid.
16. The process of claim 12 wherein the salt is sodium chloride.
17. The process of claim 12 wherein the enzyme is a protease.
18. The use of a plurality of single-celled microorganisms comprising at least one substantially inactivated single cell microorganism with at least one altered surface property, in altering at least one property of a soft material.
19. The use of claim 18 wherein the soft material is a biopolymer or a mixture of biopolymers.
20. The use of claim 18 wherein the single-celled microorganism is selected from the group consisting of fungi, algae and bacteria.
21. The use of claim 20 wherein the bacteria is Lactobacillus bulgaricus or Streptococcus thermophilus.
22. The use of claim 20 wherein the algae is chlorella or spirulina.
23. The use of claim 20 wherein the fungi is a yeast Saccharomyces cerevisiae.
24. A soft material comprising a plurality of inactivated single-celled microorganisms with at least one altered surface property wherein said microorganisms are present between about 0.1% and about 30%.
25. The soft material of claim 24 wherein the soft material is a polymer, a biopolymer or mixture of polymers or biopolymers thereof.
26. A process for preparing a modified biopolymer solution using a plurality of single- celled microorganisms comprising the steps:
1) Providing a biopolymer or a mixture of biopolymers
2) Optionally providing at least one sweetener; 3) Providing a plurality of treated single-celled microorganisms comprising at
least one substantially inactivated single cell microorganism with at least one altered surface property, and
4) Contacting said biopolymer or mixture of biopolymers with said plurality of
single-celled microorganisms and optionally with said at least one sweetener.
27. The process of claim 26 wherein the biopolymer is selected from the group consisting of gelatin, starch and combinations and-derivatives thereof.
28. The process of claim 26 wherein the sweetener is selected from a monosaccharide, disaccharide or polysaccharide, derivatives and/or modified forms thereof.
29. The process of claim 26 wherein the sweetener is selected from sucrose or glucose syrup or a combination thereof.
30. The use of a plurality of single-celled microorganisms comprising at least one substantially inactivated single cell microorganism with at least one altered surface property as a food-grade colloidal particle.
31. The use of a plurality of single-celled microorganisms comprising at least one substantially inactivated single-celled microorganism with at least one altered surface property in the preparation of a modified biopolymer solution.
32. The use of claim 31 wherein the biopolymer solution further comprises at least one ingredient selected from the group consisting of a flavouring agent, a colouring agent an acidulant, a salt, an antioxidant, an edible oil, an emulsifier and a glazing agent.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/CA2013/000823 WO2015042683A1 (en) | 2013-09-26 | 2013-09-26 | Biopolymer compositions comprising a plurality of treated single-celled microorganisms |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/CA2013/000823 WO2015042683A1 (en) | 2013-09-26 | 2013-09-26 | Biopolymer compositions comprising a plurality of treated single-celled microorganisms |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2015042683A1 true WO2015042683A1 (en) | 2015-04-02 |
Family
ID=52741663
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CA2013/000823 WO2015042683A1 (en) | 2013-09-26 | 2013-09-26 | Biopolymer compositions comprising a plurality of treated single-celled microorganisms |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2015042683A1 (en) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010002241A1 (en) * | 2008-06-30 | 2010-01-07 | N.V. Nutricia | Nutritional composition for infants delivered via caesarean section |
EP2407532A2 (en) * | 2009-03-10 | 2012-01-18 | Hero España, S.A. | Isolation, identification and characterisation of strains with probiotic activity, from faeces of infants fed exclusively with breast milk |
WO2012062868A1 (en) * | 2010-11-11 | 2012-05-18 | Nestec S.A. | Spoonable yogurt preparations containing non-replicating probiotic micro-organisms |
US20130224165A1 (en) * | 2010-11-05 | 2013-08-29 | Single Buoy Moorings, Inc | Drinking yoghurt preparations containing non-replicating probiotic micro-organisms |
-
2013
- 2013-09-26 WO PCT/CA2013/000823 patent/WO2015042683A1/en active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010002241A1 (en) * | 2008-06-30 | 2010-01-07 | N.V. Nutricia | Nutritional composition for infants delivered via caesarean section |
EP2407532A2 (en) * | 2009-03-10 | 2012-01-18 | Hero España, S.A. | Isolation, identification and characterisation of strains with probiotic activity, from faeces of infants fed exclusively with breast milk |
US20130224165A1 (en) * | 2010-11-05 | 2013-08-29 | Single Buoy Moorings, Inc | Drinking yoghurt preparations containing non-replicating probiotic micro-organisms |
WO2012062868A1 (en) * | 2010-11-11 | 2012-05-18 | Nestec S.A. | Spoonable yogurt preparations containing non-replicating probiotic micro-organisms |
Non-Patent Citations (4)
Title |
---|
BATISTA, A.P. ET AL.: "Microalgae biomass interaction in biopolymer gelled systems''.", FOOD HYDROCOLLOIDS., vol. 25, June 2011 (2011-06-01), pages 817 - 825 * |
BATISTA, A.P. ET AL.: "Novel food with microalgal ingredients - Effect of gel setting conditions on the linear viscoelasticity of Spirulina and Haematococcus gels''.", JOURNAL OF FOOD ENGINEERING., vol. 110, 11 June 2011 (2011-06-11), pages 182 - 189 * |
POORTINGA, A.T.: "Microcapsules from self-assembled colloidal particles using aqueous phase-separated polymer solutions''.", LANGMUIR., vol. 24, 4 March 2008 (2008-03-04), pages 1644 - 1647 * |
RADMER, R.J.: "Algal diversity and Commercial Algal Products''.", BIOSCIENCE., vol. 46, April 1996 (1996-04-01), pages 263 - 270 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Firoozmand et al. | Tailoring the morphology and rheology of phase-separated biopolymer gels using microbial cells as structure modifiers | |
Zheng et al. | Development of food-grade bigels based on κ-carrageenan hydrogel and monoglyceride oleogels as carriers for β-carotene: Roles of oleogel fraction | |
Zia et al. | Recent trends on gellan gum blends with natural and synthetic polymers: A review | |
Miao et al. | Fabrication of polysaccharide-based high internal phase emulsion gels: Enhancement of curcumin stability and bioaccessibility | |
Song et al. | Microencapsulated probiotics using emulsification technique coupled with internal or external gelation process | |
McClements | Designing biopolymer microgels to encapsulate, protect and deliver bioactive components: Physicochemical aspects | |
Salarbashi et al. | Fenugreek seed gum: Biological properties, chemical modifications, and structural analysis–A review | |
Wei et al. | Novel bilayer emulsions costabilized by zein colloidal particles and propylene glycol alginate, Part 1: Fabrication and characterization | |
Kowalczyk et al. | Release kinetics and antimicrobial properties of the potassium sorbate-loaded edible films made from pullulan, gelatin and their blends | |
Behera et al. | Mechanical properties and delivery of drug/probiotics from starch and non‐starch based novel bigels: A comparative study | |
Gu et al. | Influence of pH and ι-carrageenan concentration on physicochemical properties and stability of β-lactoglobulin-stabilized oil-in-water emulsions | |
Kim et al. | Microencapsulation properties of gum arabic and several food proteins: liquid orange oil emulsion particles | |
Pham-Hoang et al. | Encapsulation in a natural, preformed, multi-component and complex capsule: yeast cells | |
Peniche et al. | Formation and stability of shark liver oil loaded chitosan/calcium alginate capsules | |
Schmitt et al. | Protein–polysaccharide complexes and coacervates | |
Li et al. | Soy protein-polysaccharide complex coacervate under physical treatment: Effects of pH, ionic strength and polysaccharide type | |
Qiao et al. | Stability and rheological behaviors of different oil/water emulsions stabilized by natural silk fibroin | |
Mohammadi et al. | Development of caffeine‐encapsulated alginate‐based matrix combined with different natural biopolymers, and evaluation of release in simulated mouth conditions | |
Xu et al. | Incorporation of probiotics into 3D printed Pickering emulsion gel stabilized by tea protein/xanthan gum | |
Zhang et al. | Pickering emulsions stabilized by ovalbumin-sodium alginate coacervates | |
Zheng et al. | Pickering emulsion hydrogel based on alginate-gellan gum with carboxymethyl chitosan as a pH-responsive controlled release delivery system | |
Sun et al. | Emerging trends in pectin functional processing and its fortification for synbiotics: A review | |
US8871743B2 (en) | Bacterial cellulose composite with capsules embedded therein and preparation thereof | |
A Chaudhari et al. | Immobilization of proteins in alginate: functional properties and applications | |
Tang et al. | Fabrication of ultrastable water-in-oil high internal phase emulsion as versatile delivery vehicle through synergetic stabilization |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 13894112 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 13894112 Country of ref document: EP Kind code of ref document: A1 |